00008266752026Q1--12-31FALSEhttp://fasb.org/srt/2025#ChiefExecutiveOfficerMemberxbrli:sharesiso4217:USDxbrli:sharesiso4217:USDxbrli:puredx:segment00008266752026-01-012026-03-310000826675us-gaap:CommonStockMember2026-01-012026-03-310000826675us-gaap:SeriesCPreferredStockMember2026-01-012026-03-3100008266752026-04-2400008266752026-03-3100008266752025-12-310000826675us-gaap:AssetPledgedAsCollateralWithRightMember2026-03-310000826675us-gaap:AssetPledgedAsCollateralWithRightMember2025-12-3100008266752025-01-012025-03-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2026-01-012026-03-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2025-01-012025-03-310000826675us-gaap:PreferredStockMember2025-12-310000826675us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2025-12-310000826675us-gaap:CommonStockMember2025-12-310000826675us-gaap:AdditionalPaidInCapitalMember2025-12-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2025-12-310000826675us-gaap:CommonStockMember2026-01-012026-03-310000826675us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000826675us-gaap:PreferredStockMember2026-03-310000826675us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2026-03-310000826675us-gaap:CommonStockMember2026-03-310000826675us-gaap:AdditionalPaidInCapitalMember2026-03-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2026-03-310000826675us-gaap:PreferredStockMember2024-12-310000826675us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2024-12-310000826675us-gaap:CommonStockMember2024-12-310000826675us-gaap:AdditionalPaidInCapitalMember2024-12-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2024-12-3100008266752024-12-310000826675us-gaap:CommonStockMember2025-01-012025-03-310000826675us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000826675us-gaap:PreferredStockMember2025-03-310000826675us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2025-03-310000826675us-gaap:CommonStockMember2025-03-310000826675us-gaap:AdditionalPaidInCapitalMember2025-03-310000826675us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000826675us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2025-03-3100008266752025-03-310000826675us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310000826675us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310000826675us-gaap:PerformanceSharesMember2026-01-012026-03-310000826675us-gaap:PerformanceSharesMember2025-01-012025-03-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:InterestOnlyStripMember2026-03-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:InterestOnlyStripMember2025-12-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2026-03-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2025-12-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-01-012026-03-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-01-012025-03-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-01-012026-03-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-01-012025-03-310000826675us-gaap:InterestOnlyStripMember2026-01-012026-03-310000826675us-gaap:InterestOnlyStripMember2025-01-012025-03-310000826675us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2026-01-012026-03-310000826675us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2025-01-012025-03-310000826675us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2026-03-310000826675us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2025-12-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2026-03-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2025-12-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2026-03-310000826675us-gaap:InterestOnlyStripMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2025-12-310000826675us-gaap:MaturityUpTo30DaysMember2026-03-310000826675us-gaap:MaturityUpTo30DaysMember2025-12-310000826675us-gaap:Maturity30To90DaysMember2026-03-310000826675us-gaap:Maturity30To90DaysMember2025-12-310000826675us-gaap:MaturityOver90DaysMember2026-03-310000826675us-gaap:MaturityOver90DaysMember2025-12-310000826675us-gaap:FutureMemberus-gaap:ShortMember2026-01-012026-03-310000826675us-gaap:FutureMemberus-gaap:ShortMember2025-01-012025-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:ShortMember2026-01-012026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:ShortMember2025-01-012025-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:LongMember2025-01-012025-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:LongMember2025-01-012025-03-310000826675us-gaap:ForwardContractsMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:LongMember2025-01-012025-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:LongMember2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2025-12-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2025-12-310000826675us-gaap:FutureMember2026-03-310000826675us-gaap:InterestRateSwapMember2026-03-310000826675us-gaap:FutureMember2025-12-310000826675us-gaap:InterestRateSwapMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A35YearsMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A35YearsMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A57YearsMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A57YearsMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A710YearsMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A710YearsMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A1015YearsMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberdx:A1015YearsMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2025-12-310000826675dx:A5YearMemberus-gaap:FutureMemberus-gaap:ShortMember2026-03-310000826675dx:A5YearMemberus-gaap:FutureMemberus-gaap:ShortMember2025-12-310000826675dx:A10YearMemberus-gaap:FutureMemberus-gaap:ShortMember2026-03-310000826675dx:A10YearMemberus-gaap:FutureMemberus-gaap:ShortMember2025-12-310000826675dx:A30YearMemberus-gaap:FutureMemberus-gaap:ShortMember2026-03-310000826675dx:A30YearMemberus-gaap:FutureMemberus-gaap:ShortMember2025-12-310000826675us-gaap:FutureMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2026-03-310000826675us-gaap:FutureMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:NotDesignatedAsHedgingInstrumentTradingMemberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:NotDesignatedAsHedgingInstrumentTradingMemberus-gaap:LongMember2025-12-310000826675us-gaap:FutureMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2026-01-012026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2025-12-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2026-01-012026-03-310000826675us-gaap:InterestRateSwapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:ShortMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:NotDesignatedAsHedgingInstrumentTradingMemberus-gaap:LongMember2026-01-012026-03-310000826675us-gaap:FairValueMeasurementsRecurringMember2026-03-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-03-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-03-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-03-310000826675us-gaap:FairValueMeasurementsRecurringMember2025-12-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310000826675us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2026-03-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2025-12-310000826675us-gaap:ForwardContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2025-12-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2026-03-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2025-12-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2025-12-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2025-12-310000826675us-gaap:ExchangeTradedOptionsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2026-03-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongMember2025-12-310000826675us-gaap:InterestRateSwaptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:LongMember2025-12-310000826675us-gaap:MeasurementInputConstantPrepaymentRateMember2026-03-310000826675us-gaap:MeasurementInputConstantPrepaymentRateMember2025-12-310000826675us-gaap:MeasurementInputDefaultRateMember2026-03-310000826675us-gaap:MeasurementInputDefaultRateMember2025-12-310000826675us-gaap:MeasurementInputLossSeverityMember2026-03-310000826675us-gaap:MeasurementInputLossSeverityMember2025-12-310000826675us-gaap:MeasurementInputDiscountRateMember2025-12-310000826675us-gaap:MeasurementInputDiscountRateMember2026-03-310000826675us-gaap:SeriesCPreferredStockMember2026-03-310000826675dx:ATMOfferingMember2026-01-012026-03-310000826675us-gaap:RestrictedStockMember2025-12-310000826675us-gaap:RestrictedStockMember2024-12-310000826675us-gaap:RestrictedStockMember2026-01-012026-03-310000826675us-gaap:RestrictedStockMember2025-01-012025-03-310000826675us-gaap:RestrictedStockMember2026-03-310000826675us-gaap:RestrictedStockMember2025-03-310000826675us-gaap:RestrictedStockUnitsRSUMember2025-12-310000826675us-gaap:RestrictedStockUnitsRSUMember2024-12-310000826675us-gaap:RestrictedStockUnitsRSUMember2026-03-310000826675us-gaap:RestrictedStockUnitsRSUMember2025-03-310000826675us-gaap:PerformanceSharesMember2025-12-310000826675us-gaap:PerformanceSharesMember2024-12-310000826675us-gaap:PerformanceSharesMember2026-03-310000826675us-gaap:PerformanceSharesMember2025-03-310000826675srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2026-03-310000826675srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2026-03-310000826675srt:MinimumMemberus-gaap:PerformanceSharesMember2026-03-310000826675srt:MaximumMemberus-gaap:PerformanceSharesMember2026-03-310000826675us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2026-01-012026-03-310000826675us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-01-012026-03-310000826675us-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2026-01-012026-03-310000826675dx:DividendEquivalentRightsMember2026-03-310000826675dx:DividendEquivalentRightsMember2025-12-310000826675us-gaap:CommonStockMember2026-03-310000826675us-gaap:CommonStockMember2025-12-310000826675us-gaap:SeriesCPreferredStockMember2025-12-310000826675dx:UnpaidDividendsMember2026-03-310000826675dx:UnpaidDividendsMember2025-12-310000826675us-gaap:SubsequentEventMember2026-04-012026-04-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

FORM 10-Q

☒			Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2026

or

☐			Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-09819

DYNEX CAPITAL, INC.

(Exact name of registrant as specified in its charter)

Virginia

52-1549373

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

140 Eastshore Drive, Suite 100

Glen Allen,

Virginia

23059-5755

(Address of principal executive offices)

(Zip Code)

(804)

217-5800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

DX

New York Stock Exchange

6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share

DXPRC

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes

☒

No

☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes

☒

No

☐

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes           ☐           No            ☒

On April 24, 2026, the registrant had 215,150,907 shares outstanding of common stock, $0.01 par value, which is the registrant’s only class of common stock.

---

DYNEX CAPITAL, INC.

FORM 10-Q

INDEX

									Page
PART I. FINANCIAL INFORMATION
			Item 1.			Financial Statements
						Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025			1
						Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)			2
						Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)			3
						Consolidated Statements of Cash Flows for the three months ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)			4
						Notes to the Consolidated Financial Statements (unaudited)			6
			Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations			23
			Item 3.			Quantitative and Qualitative Disclosures About Market Risk			29
			Item 4.			Controls and Procedures			32
PART II. OTHER INFORMATION
			Item 1.			Legal Proceedings			33
			Item 1A.			Risk Factors			33
			Item 2.			Unregistered Sale of Equity and Use of Proceeds			33
			Item 3.			Defaults Upon Senior Securities			34
			Item 4.			Mine Safety Disclosures			34
			Item 5.			Other Information			34
			Item 6.			Exhibits			34
SIGNATURES									35

---

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

CONSOLIDATED BALANCE SHEETS

($s in thousands except per share data)

			March 31, 2026						December 31, 2025
ASSETS			(unaudited)
Cash and cash equivalents			$	773,138					$	531,043
Cash collateral posted to counterparties			516,502						399,344
Mortgage-backed securities (including pledged assets of $22,120,332 and $14,593,470, respectively), at fair value			22,943,257						16,306,988
Due from counterparties			3,434						17,425
Derivative assets			695						10,498
Accrued interest receivable			97,454						67,940
Other assets			8,872						8,940
Total assets			$	24,343,352					$	17,342,178
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities:
Repurchase agreements			$	21,045,457					$	13,904,231
Due to counterparties			379,893						811,656
Derivative liabilities			14,121						4,830
Cash collateral posted by counterparties			—						8,373
Accrued interest payable			131,426						95,196
Dividends payable			41,893						37,171
Other liabilities			9,292						18,577
Total liabilities			21,622,082						14,880,034
Shareholders’ equity:
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively)			107,843						107,843
Common stock, par value $0.01 per share, 360,000,000 shares authorized; 207,154,465 and 174,814,912 shares issued and outstanding, respectively			2,072						1,748
Additional paid-in capital			3,368,130						2,921,551
Accumulated other comprehensive loss			(127,209)						(127,061)
Accumulated deficit			(629,566)						(441,937)
Total shareholders’ equity			2,721,270						2,462,144
Total liabilities and shareholders’ equity			$	24,343,352					$	17,342,178

See notes to the unaudited consolidated financial statements.

1

---

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

($s in thousands except per share data)

			Three Months Ended
			March 31,
			2026						2025
INTEREST INCOME (EXPENSE)
Interest income			$	257,390					$	95,059
Interest expense			(178,136)						(77,926)
Net interest income			79,254						17,133
OTHER GAINS (LOSSES)
Realized gain on sales of investments, net			8,721						—
Unrealized (loss) gain on investments, net			(251,811)						109,997
Gain (loss) on derivative instruments, net			104,727						(118,088)
Total other gains (losses), net			(138,363)						(8,091)
EXPENSES
Compensation and benefits			(15,309)						(7,919)
Other general and administrative			(5,169)						(3,845)
Other operating expenses			(775)						(354)
Total operating expenses			(21,253)						(12,118)
Net loss			(80,362)						(3,076)
Preferred stock dividends			(2,658)						(1,923)
Net loss to common shareholders			$	(83,020)					$	(4,999)
Other comprehensive income:
Unrealized (loss) gain on available-for-sale investments			$	(148)					$	19,390
Total other comprehensive (loss) income			(148)						19,390
Comprehensive (loss) income to common shareholders			$	(83,168)					$	14,391
Weighted average common shares-basic			200,084,349						90,492,327
Weighted average common shares-diluted			200,084,349						90,492,327
Net loss per common share-basic			$	(0.41)					$	(0.06)
Net loss per common share-diluted			$	(0.41)					$	(0.06)

See notes to the unaudited consolidated financial statements.

2

---

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)

($s in thousands)

			For the Three Months Ended March 31, 2026
			Preferred Stock									Common Stock									Additional Paid-in Capital						Accumulated Other Comprehensive Loss						Accumulated Deficit						Total Shareholders’ Equity
			Shares			Amount						Shares			Amount
Balance as of December 31, 2025			4,460,000			$	107,843					174,814,912			$	1,748					$	2,921,551					$	(127,061)					$	(441,937)					$	2,462,144
Stock issuance			—			—						32,101,365			321						441,422						—						—						441,743
Share-based compensation, net of amortization			—			—						406,946			4						7,662						—						—						7,666
Adjustments for tax withholding on share-based compensation			—			—						(168,758)			(1)						(2,366)						—						—						(2,367)
Stock issuance costs			—			—						—			—						(139)						—						—						(139)
Net loss			—			—						—			—						—						—						(80,362)						(80,362)
Dividends on preferred stock			—			—						—			—						—						—						(2,658)						(2,658)
Dividends on common stock			—			—						—			—						—						—						(104,609)						(104,609)
Other comprehensive loss			—			—						—			—						—						(148)						—						(148)
Balance as of March 31, 2026			4,460,000			$	107,843					207,154,465			$	2,072					$	3,368,130					$	(127,209)					$	(629,566)					$	2,721,270
			For the Three Months Ended March 31, 2025
Balance as of December 31, 2024			4,460,000			$	107,843					84,491,800			$	845					$	1,742,471					$	(172,489)					$	(493,734)					$	1,184,936
Stock issuance			—			—						17,604,999			176						239,482						—						—						239,658
Share-based compensation, net of amortization			—			—						188,702			2						2,027						—						—						2,029
Adjustments for tax withholding on share-based compensation			—			—						(59,146)			(1)						(1,180)						—						—						(1,181)
Stock issuance costs			—			—						—			—						(19)						—						—						(19)
Net loss			—			—						—			—						—						—						(3,076)						(3,076)
Dividends on preferred stock			—			—						—			—						—						—						(1,923)						(1,923)
Dividends on common stock			—			—						—			—						—						—						(43,899)						(43,899)
Other comprehensive income			—			—						—			—						—						19,390						—						19,390
Balance as of March 31, 2025			4,460,000			$	107,843					102,226,355			$	1,022					$	1,982,781					$	(153,099)					$	(542,632)					$	1,395,915

See notes to the unaudited consolidated financial statements.

3

---

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)
($s in thousands)

			Three Months Ended
			March 31,
			2026						2025
Operating activities:
Net loss			$	(80,362)					$	(3,076)
Adjustments to reconcile net loss to cash provided by operating activities:
Realized gain on sales of investments, net			(8,721)						—
Unrealized loss (gain) on investments, net			251,811						(109,997)
(Gain) loss on derivative instruments,net			(104,727)						118,088
Amortization of investment premiums, net			5,951						7,961
Other amortization and depreciation			545						496
Share-based compensation expense			7,666						2,029
Increase in accrued interest receivable			(29,514)						(3,845)
Increase in accrued interest payable			36,230						2,189
Change in other assets and liabilities, net			(9,030)						(7,482)
Net cash provided by operating activities			69,849						6,363
Investing activities:
Purchases of investments			(8,453,854)						(957,078)
Principal payments received on trading securities			453,334						120,906
Principal payments received on available-for-sale investments			18,000						59,986
Proceeds from sales of trading securities			633,301						—
Principal payments received on mortgage loans held for investment			17						67
Net receipts (payments) on derivative instruments			169,042						(137,035)
(Decrease) increase in cash collateral posted by counterparties			(8,373)						4,798
Net cash used in investing activities			(7,188,533)						(908,356)
Financing activities:
Borrowings under repurchase agreements			51,354,129						22,760,699
Repayments of repurchase agreement borrowings			(44,212,903)						(22,089,096)
Proceeds from issuance of common stock			441,743						239,658
Cash paid for stock issuance costs			(120)						—
Payments related to tax withholding for share-based compensation			(2,367)						(1,181)
Dividends paid			(102,545)						(41,616)
Net cash provided by financing activities			7,477,937						868,464
Net increase (decrease) in cash, including cash posted to counterparties			359,253						(33,529)
Cash including cash collateral posted to counterparties at beginning of period			930,387						621,539
Cash including cash collateral posted to counterparties at end of period			$	1,289,640					$	588,010
Supplemental Disclosure of Cash Activity:
Cash paid for interest on repurchase agreements			$	141,905					$	75,738
Noncash Investing Activities:

4

---

Payable for investments pending settlement			$	347,107					$	325,401

See notes to the unaudited consolidated financial statements.

5

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc. (“Dynex” or the “Company”) is a real estate investment trust (“REIT”) structured to deliver dividends to shareholders supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company’s common stock and preferred stock trade on the New York Stock Exchange (“NYSE”) under the ticker symbols “DX” and “DXPRC”, respectively.

The Company is internally managed and primarily earns income from investing in residential and commercial mortgage-backed securities (“RMBS” and “CMBS”, respectively), which are backed by residential and commercial mortgage loans, and which are Agency securities guaranteed by U.S. government-sponsored enterprises (“GSEs”). The Company may also invest in other mortgage-related assets consistent with its objectives. Dynex actively manages interest rate, prepayment, spread, liquidity, and counterparty risks. The Dynex approach emphasizes risk management and disciplined capital allocation designed to preserve book value and support dividends across market cycles.

Basis of Presentation

The accompanying unaudited consolidated financial statements of the Company and its subsidiaries (together, “Dynex” or, as appropriate, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair statement of results for the interim period have been included. All intercompany accounts and transactions have been eliminated in consolidation. Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2026. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”) filed with the SEC. 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimate used by management relates to the fair value measurement of its investments, including TBA securities accounted for as derivative instruments, which is discussed further below within this note to the consolidated financial statements. The Company believes the estimates and assumptions underlying the consolidated financial statements included herein are reasonable and supportable based on the information available as of March 31, 2026.

Consolidation and Variable Interest Entities

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

The Company did not consolidate any variable interest entities (“VIEs”) as of March 31, 2026. The Company consolidates a VIE if the Company is determined to be the VIE’s primary beneficiary, which is defined as the party that has both (i) the power to control the activities that most significantly impact the VIE’s financial performance; and (ii) the right to receive benefits or absorb losses that could potentially be significant to the VIE. The Company reconsiders its evaluation of whether to consolidate a VIE on an ongoing basis, based on changes in the facts and circumstances pertaining to the VIE. Though the Company invests in Agency and non-Agency MBS which are generally considered to be interests in VIEs, the Company does not consolidate these entities because it does not meet the criteria to be deemed the primary beneficiary. The maximum exposure to loss for these VIEs is the carrying value of the MBS.

6

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Income Taxes

The Company has elected to be taxed as a REIT under the Internal Revenue Code of 1986 (the “Tax Code”) and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain asset, income, ownership, and distribution tests. To meet these requirements, the Company’s main source of income is interest earned from obligations secured by mortgages on real property, and the Company must distribute at least 90% of its annual REIT taxable income to shareholders. The Company’s income will generally not be subject to federal income tax to the extent its income is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities and records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Net Income (Loss) Per Common Share

The Company calculates basic net income (loss) per common share by dividing net income (loss) to common shareholders for the period by weighted-average shares of common stock outstanding for that period. Please see Note 2 for the calculation of the Company’s basic and diluted net income (loss) per common share for the periods indicated.

The Company currently has restricted stock, service-based restricted stock units (“RSUs”) and performance-based stock units (“PSUs”) issued and outstanding. Restricted stock awards issued under the Company’s 2020 Stock and Incentive Plan (the “2020 Plan”) are considered participating securities and therefore are included in the computation of basic net income per common share using the two-class method because holders of unvested shares of restricted stock issued are eligible to receive non-forfeitable dividends. Holders of RSUs and PSUs issued under the 2020 Plan as well as the Company’s 2025 Stock and Incentive Plan (the “2025 Plan”) accrue forfeitable dividend equivalent rights ("DERs") over the period outstanding, receiving dividend payments only upon the settlement date if the requisite service-based and performance-based conditions have been achieved, as applicable. As such, RSUs and PSUs are excluded from the computation of basic net income per common share but are included in the computation of diluted net income per common share using the treasury stock method unless the effect is to reduce a net loss or increase the net income per common share (also known as “anti-dilutive”). Upon vesting, restrictions on transfer expire on each share of restricted stock, RSU, and PSU, and each such share or unit becomes one unrestricted share of common stock and is included in the computation of basic net income per common share.

Because the Company’s 6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the “Series C Preferred Stock”) is redeemable at the Company’s option for cash only and convertible into shares of common stock only upon a change of control of the Company (and subject to other circumstances) as described in Article IIIC of the Company’s Restated Articles of Incorporation, as amended, the effect of those shares and their related dividends are excluded from the calculation of diluted net income per common share for the periods presented.

Cash and Cash Equivalents

Cash and cash equivalents include unrestricted demand deposits at highly rated financial institutions and highly liquid investments with original maturities of three months or less. The Company’s cash balances fluctuate throughout the year and may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits from time to time. Although the Company bears risk on amounts in excess of those insured by the FDIC, the Company believes the risk of loss is mitigated by the financial position, creditworthiness, and strength of the depository institutions in which those deposits are held.

Cash Collateral Posted To/By Counterparties

The Company regularly pledges and receives amounts to cover margin requirements related to the Company’s financing and derivative instruments. If the amount pledged to a counterparty exceeds the amount received from a counterparty, the net amount is recorded as an asset within “cash collateral posted to counterparties,” and if the amount received from a counterparty exceeds the amount pledged to a counterparty, the

7

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

net amount is recorded as a liability within “cash collateral posted by counterparties” on the Company’s consolidated balance sheets.

The following table provides a reconciliation of “cash” and “cash posted to counterparties” reported on the Company's consolidated balance sheet as of March 31, 2026 presented herein that sum to the total of the same such amounts shown on the Company’s consolidated statement of cash flows for the three months ended March 31, 2026:

($s in thousands)			March 31, 2026
Cash and cash equivalents			$	773,138
Cash collateral posted to counterparties			516,502
Total cash including cash posted to counterparties shown on consolidated statement of cash flows			$	1,289,640

Mortgage-Backed Securities 

The Company’s MBS are recorded at fair value on the Company’s consolidated balance sheet. Changes in fair value of MBS purchased prior to January 1, 2021 are designated as available-for-sale (“AFS”) with changes in fair value reported in other comprehensive income (“OCI”) as an unrealized gain (loss) until the security is sold or matures. Effective January 1, 2021, the Company elected the fair value option (“FVO”) for all MBS purchased on or after that date with changes in fair value reported in net income as “unrealized gain (loss) on investments, net” until the security is sold or matures. Management elected the fair value option so that net income will reflect the changes in fair value for its future purchases of MBS in a manner consistent with the presentation and timing of the changes in fair value of its derivative instruments. Upon the sale of an MBS, any unrealized gain or loss within OCI or net income is reclassified to “realized gain (loss) on sale of investments, net” within net income using the specific identification method.

Interest Income, Premium Amortization, and Discount Accretion. Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of IO securities) and the contractual terms. Premiums or discounts associated with the purchase of MBS are amortized or accreted into interest income over the life of such securities using the effective interest method, and adjustments to premium amortization and discount accretion are made for actual cash payments received. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flows and updates the yield recognized on these assets.

Determination of MBS Fair Value. The Company estimates the fair value of the majority of its MBS based upon prices obtained from an independent third-party pricing service. These prices are assessed for reasonableness using additional third-party pricing services. Please refer to Note 6 for further discussion of MBS fair value measurements.

Allowance for Credit Losses. On at least a quarterly basis, the Company evaluates any MBS designated as AFS with a fair value less than its amortized cost for credit losses. If the difference between the present value of cash flows expected to be collected on the MBS is less than its amortized cost, the difference is recorded as an allowance for credit loss through net income up to and not exceeding the amount that the amortized cost exceeds current fair value. Subsequent changes in credit loss estimates are recognized in earnings in the period in which they occur. Because the majority of the Company’s investments are higher credit quality and most are guaranteed by a GSE, the Company is not likely to have an allowance for credit losses related to its MBS recorded on its consolidated balance sheet.

Interest accrued between payment dates on MBS is presented separately from the Company’s investment portfolio as “accrued interest receivable” on its consolidated balance sheet. The Company does not estimate an allowance for credit loss for its accrued interest receivable because the interest is generally received within 30 days and amounts not received when due are written off against interest income.

Repurchase Agreements

The Company’s repurchase agreements are used to finance its purchases of MBS. The Company pledges its securities as collateral to secure a loan, which is equal to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. Pursuant to Accounting

8

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Standards Codification (“ASC”) Topic 860, the Company accounts for repurchase agreements as collateralized financing transactions, which are carried at their contractual amounts (cost), plus accrued interest. The interest rates the Company pays for these borrowings are based on a spread added to the Secured Overnight Funding Rate (“SOFR”). At the maturity of a repurchase agreement borrowing, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender, or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. The repurchase facilities available to the Company are uncommitted with no guarantee of renewal.

Derivative Instruments

Derivative instruments are carried at fair value, and all periodic interest benefits/costs and changes in the fair value of derivative instruments, including gains and losses realized upon termination, maturity, or settlement, are recorded in “gain (loss) on derivative instruments, net” on the Company’s consolidated statements of comprehensive income (loss). Cash receipts and payments related to derivative instruments are classified in the investing activities section of the consolidated statements of cash flows in accordance with the underlying nature or purpose of the derivative transactions.

The Company’s short positions in U.S. Treasury futures contracts are centrally cleared through the Chicago Mercantile Exchange (“CME”), which requires the Company to post initial margin as determined by the CME. Daily variation margin is exchanged, typically in cash, for the changes in the fair value of the futures contracts, which is treated as legal settlement of the exposure under the related futures contracts as opposed to a pledge of collateral. The effect of these legal settlements reduces what would have otherwise been reported as the fair value of the futures contracts, generally to $0. The margin requirement varies based on the market value of the open positions and the equity retained in the account. Any margin excess or deficit outstanding is recorded as a receivable or payable within “due from/to counterparties” as of the date of the Company’s consolidated balance sheets. The Company realizes gains or losses on these contracts upon expiration at an amount equal to the difference between the current fair value of the underlying asset and the contractual price of the futures contract.

The Company’s interest rate swaps are pay-fixed, which involve the receipt of variable-rate amounts based on SOFR from a counterparty in exchange for the Company making fixed-rate payments over the life of the interest rate swap without exchange of the underlying notional amount. The net periodic interest benefit (cost) is recorded in the period earned (incurred) in “gain (loss) on derivative instruments, net”, but the net receipt (payment) of cash is exchanged annually, typically on the anniversary of each agreement’s effective date. Similar to the Company’s U.S. Treasury futures, interest rate swap agreements are centrally cleared through the CME with requirements to post initial margin and to exchange daily variation margin amounts, which are treated as legal settlements of the agreements. Any margin excess or deficit outstanding is recorded as a receivable or payable within “due from/to counterparties” as of the date of the Company’s consolidated balance sheets.

The Company’s interest rate swaptions are SOFR-based and provide the Company the right, but not the obligation, to enter into an interest rate swap at a predetermined notional amount with a stated term and pay and receive rates in the future. These agreements are entered into directly with a counterparty (a “bilateral contract”) with whom we may exchange margin collateral. Because these agreements are not centrally cleared, the Company has exposure to counterparty risk. The Company records the premium it will pay for the swaption as a derivative asset on its consolidated balance sheet and adjusts the balance for changes in fair value through “gain (loss) on derivative instruments” until the swaption is exercised or the contract expires. If the swaption expires unexercised, the realized loss is limited to the premium paid. If exercised, the realized gain or loss on the swaptions is equal to the difference between the fair value of the underlying interest rate swap and the premium paid.

The Company may also use options on U.S. Treasury futures, which are initially recorded at the price of the premium paid at inception. Subsequent changes in fair value are recorded in “gain (loss) on derivatives instruments” until the option is exercised or the contract expires. If the option expires unexercised, the realized loss is limited to the premium paid at inception. If exercised, the realized gain or loss on the option is equal to the difference between the fair value of the underlying U.S. Treasury future and the premium paid at inception.

The Company purchases to-be-announced (“TBA”) securities as a means of investing in non-specified

9

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

fixed-rate Agency RMBS and may also periodically sell TBA securities as a means of economically hedging its exposure to Agency RMBS. A TBA security is a forward contract (“TBA contract”) for the purchase (“long position”) or sale (“short position”) of a non-specified Agency MBS at a predetermined price with certain principal and interest terms and certain types of collateral, but the particular Agency securities to be delivered are not identified until shortly before the settlement date. The Company accounts for long and short positions in Agency RMBS TBAs as derivative instruments in accordance with ASC 815 because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS or that the individual TBA transaction will settle in the shortest time period possible.

Please refer to Note 5 for additional information regarding the Company’s derivative instruments as well as Note 6 for information on how the fair value of these instruments is calculated.

Share-Based Compensation

The Company’s 2025 Plan reserves for issuance up to 12,000,000 common shares for eligible employees, non-employee directors, consultants, and advisors to the Company to be granted in the form of stock options, restricted stock, RSUs, stock appreciation rights, PSUs, and performance-based cash awards (collectively, “awards”). Awards previously granted under the 2020 Plan will remain outstanding and valid in accordance with their terms, but no new awards will be granted under the 2020 Plan. As of March 31, 2026, there were 9,426,189 common shares remaining available for issuance under the 2025 Plan.

The Company has issued restricted stock and RSUs, which are treated as equity awards and recorded at their fair value using the closing stock price on the grant date. Compensation expense is generally recognized over a service period specified within each award with a corresponding credit to shareholders’ equity using the straight-line method until the vesting date specified within each award or until the employee becomes eligible for retirement, if earlier than the vesting date. Compensation expense is recognized immediately upon the grant date for equity awards granted to an employee who is retirement eligible.

The Company also has PSUs issued and outstanding which contain Company performance-based conditions. PSUs subject to Company performance-based conditions are initially recognized as equity at their fair value which is measured using the closing stock price on the grant date multiplied by the number of units expected to vest based on an assessment of the probability of achievement of the Company performance-based conditions as of the grant date. The grant date fair value is recognized as expense using the straight-line method until the earlier of the vesting date specified within each award or the date the employee becomes eligible for retirement. Adjustments are made, if necessary, based on any change in probability of achievement which is re-assessed as of each reporting date and on at least a quarterly basis.

The Company does not estimate forfeitures for any of its share-based compensation awards but adjusts for actual forfeitures in the periods in which they occur. Because RSUs and PSUs have forfeitable DERs, which are paid in cash only upon settlement, any accrued DERs on forfeited units are reversed with a corresponding credit to “Compensation and benefits” expense.

Please see Note 7 for additional information about the Company’s share-based compensation awards.

Contingencies

From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of its business. In the opinion of management, the Company did not have any material pending lawsuits, claims, or other contingencies as of March 31, 2026 or December 31, 2025.

Recently Issued Accounting Pronouncements

The Company evaluates Accounting Standards Updates (“ASU”) issued by the Financial Accounting Standards Board on at least a quarterly basis to evaluate applicability and significance of any impact on its financial condition and results of operations. There are no new accounting pronouncements which are not yet effective that are expected to have a significant impact on our consolidated financial statements upon adoption.

10

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – NET INCOME (LOSS) PER COMMON SHARE

Please refer to Note 1 for information regarding the Company’s treatment of its preferred stock and stock awards in the calculation of its basic and diluted net income or loss per common share and to Note 7 for information regarding the Company’s stock award activity for the periods presented. The following table presents the computations of basic and diluted net income or loss per common share for the periods indicated:

			Three Months Ended
			March 31,
($s in thousands)			2026						2025
Weighted average number of common shares outstanding - basic			200,084,349						90,492,327
Incremental common shares-unvested RSUs			—						—
Incremental common shares-unvested PSUs			—						—
Weighted average number of common shares outstanding - diluted			200,084,349						90,492,327
Net loss to common shareholders			$	(83,020)					$	(4,999)
Net loss per common share-basic			$	(0.41)					$	(0.06)
Net loss per common share-diluted			$	(0.41)					$	(0.06)

The calculation of diluted net loss per common share for the three months ended March 31, 2026 and March 31, 2025 excludes unvested RSUs and PSUs of 1,303,235 and 547,845, respectively, which would have been anti-dilutive for the period.

11

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 – MORTGAGE-BACKED SECURITIES

 

The following tables provide details on the Company’s MBS by investment type as of the dates indicated:

			March 31, 2026
($s in thousands)			Agency RMBS						Agency CMBS						CMBS IO (1)						Total
Measured at fair value through net income:
Amortized cost			$	21,113,033					$	1,199,336					$	29,425					$	22,341,794
Gross unrealized gain			114,040						5,226						6						119,272
Gross unrealized loss			(222,416)						(4,908)						(1,180)						(228,504)
Fair value through net income			$	21,004,657					$	1,199,654					$	28,251					$	22,232,562
Measured at fair value through OCI:
Amortized cost			$	738,635					$	47,211					$	52,058					$	837,904
Gross unrealized gain			—						19						2,763						2,782
Gross unrealized loss			(126,078)						(2,083)						(1,830)						(129,991)
Fair value through OCI			$	612,557					$	45,147					$	52,991					$	710,695
Total			$	21,617,214					$	1,244,801					$	81,242					$	22,943,257
			December 31, 2025
			Agency RMBS						Agency CMBS						CMBS IO (1)						Total
Measured at fair value through net income:
Amortized cost			$	14,233,682					$	1,165,674					$	30,680					$	15,430,036
Gross unrealized gain			236,304						8,293						20						244,617
Gross unrealized loss			(99,899)						(995)						(1,147)						(102,041)
Fair value through net income			$	14,370,087					$	1,172,972					$	29,553					$	15,572,612
Measured at fair value through OCI:
Amortized cost			$	757,127					$	47,433					$	56,877					$	861,437
Gross unrealized gain			—						25						2,620						2,645
Gross unrealized loss			(125,854)						(2,087)						(1,765)						(129,706)
Fair value through OCI			$	631,273					$	45,371					$	57,732					$	734,376
Total			$	15,001,360					$	1,218,343					$	87,285					$	16,306,988
(1) The Company held a notional balance of Agency CMBS IO and non-Agency CMBS IO of $4,771,493 and $1,019,323, respectively, as of March 31, 2026, and $4,928,803 and $1,071,722, respectively, as of December 31, 2025.

The majority of the Company’s MBS are pledged as collateral for the Company’s repurchase agreements, which are disclosed in Note 4. Actual maturities of MBS are affected by the contractual lives of the underlying mortgage collateral, scheduled payments, and unscheduled prepayments of principal, and the payment priority structure of the security; therefore, actual maturities are generally shorter than the securities' stated contractual maturities.

12

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The following table presents information regarding unrealized gains and losses on investments reported within net income (loss) on the Company’s consolidated statements of comprehensive income (loss) for the periods indicated:

			Three Months Ended
			March 31,
($s in thousands)			2026						2025
Agency RMBS			$	(244,781)					$	109,260
Agency CMBS			(6,981)						110
CMBS IO			(47)						609
Other investments			(2)						18
Unrealized (loss) gain on investments, net			$	(251,811)					$	109,997

The following table presents information regarding realized gains and losses on sales of MBS reported in the Company’s consolidated statements of comprehensive income (loss) for the periods indicated:

			Three Months Ended
			March 31,
($s in thousands)			2026						2025
Realized gain on sales of MBS - FVO			$	8,721					$	—
Realized loss on sale of MBS - FVO			—						—
Total realized gain on sales of investments, net			$	8,721					$	—

The following table presents certain information for MBS designated as AFS that were in an unrealized loss position as of the dates indicated:

						March 31, 2026																		December 31, 2025
($s in thousands)						Fair Value						Gross Unrealized Losses						# of Securities						Fair Value						Gross Unrealized Losses						# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS						$	1,459					$	(15)					3						$	730					$	(1)					2
Non-Agency MBS						16						(1)						1						208						(22)						3
Continuous unrealized loss position for 12 months or longer:
Agency MBS						$	698,491					$	(129,959)					54						$	721,536					$	(129,658)					56
Non-Agency MBS						391						(16)						3						752						(25)						3

The unrealized loss positions on the Company’s MBS designated as AFS as of March 31, 2026 and December 31, 2025 were the result of higher interest rates and wider spreads to U.S. Treasuries compared to at the time of purchase. The unrealized loss positions are not credit related; therefore, the Company did not record an allowance for credit losses as of March 31, 2026 or December 31, 2025. The Company has the ability and intent to hold any MBS with an unrealized loss until the recovery in its value. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s leverage and liquidity position. In addition, for its non-Agency MBS, which are not guaranteed by a GSE, the Company reviews the credit ratings, the credit characteristics of the mortgage loans collateralizing these securities, and the estimated future cash flows including projected collateral losses.

13

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 – REPURCHASE AGREEMENTS

The Company’s repurchase agreements outstanding as of March 31, 2026 and December 31, 2025 are summarized in the following tables:

						March 31, 2026																		December 31, 2025
Collateral Type						Balance						Weighted Average Rate						Fair Value of Collateral Pledged (1)						Balance						Weighted Average Rate						Fair Value of Collateral Pledged (1)
($s in thousands)
Agency RMBS						$	19,845,289					3.80		%				$	20,871,318					$	12,857,827					4.09		%				$	13,496,489
Agency CMBS						1,125,561						3.81		%				1,170,554						967,024						4.07		%				1,012,532
Agency CMBS IO						72,929						4.15		%				76,577						77,057						4.41		%				81,913
Non-Agency CMBS IO						1,678						4.57		%				1,883						2,323						4.72		%				2,536
Total						$	21,045,457					3.80		%				$	22,120,332					$	13,904,231					4.10		%				$	14,593,470

(1) Amounts disclosed for fair value of collateral pledged include amounts pledged to cover margin calls, which may differ in collateral type from the initial collateral type pledged.

The Company’s equity at risk did not exceed 10% with any single counterparty as of March 31, 2026.

The following table provides information on the remaining term to maturity and original term to maturity for the Company’s repurchase agreements as of the dates indicated:

						March 31, 2026																		December 31, 2025
Remaining Term to Maturity						Balance						Weighted Average Rate						WAVG Original Term to Maturity						Balance						Weighted Average Rate						WAVG Original Term to Maturity
($s in thousands)
Less than 30 days						$	8,026,127					3.81		%				77						$	9,146,566					4.11		%				75
30 to 90 days						12,451,246						3.80		%				95						4,757,665						4.07		%				94
91 to 180 days						568,084						3.75		%				173						—						—		%				—
Total						$	21,045,457					3.80		%				90						$	13,904,231					4.10		%				81

The Company’s accrued interest payable related to its repurchase agreement borrowings increased to $131 million as of March 31, 2026 from $95 million as of December 31, 2025.

The Company’s counterparties, as set forth in the master repurchase agreement with each counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company’s REIT status. In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company believes it was in full compliance with all covenants in master repurchase agreements under which there were amounts outstanding as of March 31, 2026.

The Company's repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of set off in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its repurchase agreements to these arrangements on a gross basis. The following table presents information regarding the Company's repurchase agreements as if the Company had

14

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

presented them on a net basis as of March 31, 2026 and December 31, 2025:

($s in thousands)			Gross Amount of Recognized Liabilities						Gross Amount Offset in the Balance Sheet						Net Amount of Liabilities Presented in the Balance Sheet						Gross Amount Not Offset in the Balance Sheet (1)												Net Amount
																					Financial Instruments Posted as Collateral						Cash Posted as Collateral
March 31, 2026:
Repurchase agreements			$	21,045,457					$	—					$	21,045,457					$	(21,045,457)					$	—					$	—
December 31, 2025:
Repurchase agreements			$	13,904,231					$	—					$	13,904,231					$	(13,904,231)					$	—					$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the repurchase agreement liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically, and the total cash pledged or received as collateral, which is disclosed as “cash collateral posted to/by counterparties.”

Please see Note 5 for information related to the Company’s derivatives, which are also subject to underlying agreements with master netting or similar arrangements.

NOTE 5 – DERIVATIVES

Types and Uses of Derivatives Instruments

Interest Rate Derivatives. The Company frequently changes the type of derivative instruments it uses to mitigate the impact of changing interest rates on its repurchase agreement financing costs and the fair value of its investments. Please refer to Note 1 for descriptions of these instruments and how the Company accounts for them.

TBA Transactions. The Company purchases TBA securities as a means of investing in non-specified fixed-rate Agency RMBS and may also periodically sell TBA securities as a means of economically hedging its exposure to Agency RMBS. Please refer to Note 1 for more information about these securities.

The table below provides detail of the Company’s gain and losses by type of derivative instrument for the periods indicated:

						Three Months Ended
						March 31,
Type of Derivative Instrument						2026						2025
($s in thousands)
U.S. Treasury futures						$	35,308					$	(44,347)
Interest rate swaps						86,289						(116,726)
Interest rate swaptions						(335)						811
Options on U.S. Treasury futures						(2,656)						—
TBA securities						(13,879)						42,174
Gain (loss) on derivative instruments, net						$	104,727					$	(118,088)

The table below provides the carrying amount by type of derivative instrument comprising the Company’s derivative assets and liabilities on its consolidated balance sheets as of the dates indicated:

15

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Type of Derivative Instrument						Balance Sheet Location						Purpose						March 31, 2026						December 31, 2025
($s in thousands)
Options on U.S. Treasury futures						Derivative assets						Economic hedging						$	—					$	2,657
TBA securities						Derivative assets						Investing						695						7,841
Total derivatives assets																		$	695					$	10,498
Interest rate swaptions						Derivative liabilities						Economic hedging						$	4,380					$	4,045
TBA securities						Derivative liabilities						Investing						9,741						785
Total derivatives liabilities																		$	14,121					$	4,830

The table below presents information regarding the long positions in SOFR-based interest rate swaptions and options on U.S. Treasury futures held by the Company as of the dates indicated:

			Option																								Underlying Financial Instrument
($s in thousands)			Cost (1)						Fair Value						Carrying Value (1)						Notional Amount						Average Fixed Receive Rate						Type of Instrument
As of March 31, 2026:
1-2 year interest rate swaptions			$	11,725					$	7,345					$	(4,380)					$	750,000					3.25%						5 year SOFR-based swap
3-month options on U.S. Treasury futures			—						—						—						—						n/a						10-year U.S. Treasury future
As of December 31, 2025:
1-2 year interest rate swaptions			$	11,725					$	7,680					$	(4,045)					$	750,000					3.25%						5 year SOFR-based swap
3-month options on U.S. Treasury futures			3,981						2,657						2,657						500,000						n/a						10-year U.S. Treasury future

(1)The Company pays the premium for its interest rate swaptions at the end of the option period, so the carrying value on the Company's consolidated balance sheets is fair value, net of the payable for the unpaid premium as of the periods indicated. The Company pays the premium for its options on U.S. Treasury futures at inception, so the carrying value is equal to the fair value as of the periods indicated.

Because the daily margin exchanged for the Company’s U.S. Treasury futures and interest rate swaps are considered legal settlement of the derivative as opposed to a pledge of collateral, these instruments have a carrying value of $0 on the Company’s consolidated balance sheets. The Company’s U.S. Treasury futures, excluding the recognition of variation margin settlements, were in a net asset position of $58 million as of March 31, 2026 and a net asset position of $22 million as of December 31, 2025, and its interest rate swaps were in a net asset position of $39 million as of March 31, 2026 and net liability position of $(46) million as of December 31, 2025. The amount of cash posted by the Company to cover required initial margin for its U.S. Treasury futures and its interest rate swaps was $486 million as of March 31, 2026 and $392 million as of December 31, 2025, which was recorded within “cash collateral posted to counterparties.” The Company had a margin payable of $26 million as of March 31, 2026 recorded within “due to counterparties” and $17 million as of December 31, 2025 recorded within “due from counterparties.”

The table below presents information regarding the pay fixed/receive variable SOFR-based interest rate swaps the Company held as of the dates indicated:

16

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

						March 31, 2026												December 31, 2025
Pay Fixed Interest Rate Swaps - Years to Maturity						Notional Amount						Weighted Average Pay Fixed Rate						Notional Amount						Weighted Average Pay Fixed Rate
($s in thousands)
3-5 years						$	4,400,000					3.43		%				$	2,450,000					3.42		%
5-7 years						4,060,000						3.65		%				4,070,000						3.66		%
7-10 years						4,120,000						3.85		%				3,090,000						3.87		%
10-15 years						—						—		%				75,000						3.77		%
						$	12,580,000					3.64		%				$	9,685,000					3.66		%

The table below presents information regarding the notional amounts of the short positions in U.S. Treasury futures held by the Company as of the dates indicated:

U.S. Treasury Futures						March 31, 2026						December 31, 2025
($s in thousands)
5-year U.S. Treasury futures						$	—					$	(30,000)
10-year U.S. Treasury futures						(1,917,500)						(1,475,000)
30-year U.S. Treasury futures						(1,231,600)						(1,153,500)
						$	(3,149,100)					$	(2,658,500)

The following table summarizes information about the notional amounts of the Company's long positions in TBA securities as of the dates indicated:

TBA securities						March 31, 2026						December 31, 2025
($s in thousands)
Implied market value (1)						$	1,822,047					$	3,121,122
Implied cost basis (2)						1,831,093						3,114,066
Net carrying value (3)						$	(9,046)					$	7,056

(1) Implied market value represents the estimated fair value of the underlying Agency MBS as of the dates indicated.

(2) Implied cost basis represents the forward price to be paid for the underlying Agency MBS as of the dates indicated.

(3) Net carrying value represents the difference between the implied market value and the implied cost basis of the Company’s TBA securities as of the dates indicated. The total shown is the net amount included on the consolidated balance sheets as derivative assets of $695 and derivative liabilities of $9,741 as of March 31, 2026 and $7,841 and $785, respectively, as of December 31, 2025.

Volume of Activity

The table below summarizes changes in the Company’s derivative instruments for the three months ended March 31, 2026:

Type of Derivative Instrument						Beginning Notional Amount-Long (Short)						Additions						Settlements, Terminations, or Pair-Offs						Ending Notional Amount-Long (Short)
($s in thousands)
U.S. Treasury futures						$	(2,658,500)					$	(6,489,700)					$	5,999,100					$	(3,149,100)
Interest rate swaps						9,685,000						2,905,000						(10,000)						12,580,000
Interest rate swaptions						750,000						—						—						750,000
Options on U.S. Treasury futures						500,000						—						(500,000)						—
TBA securities						3,189,000						12,782,000						(14,111,000)						1,860,000

17

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Offsetting

The Company's derivatives are subject to underlying agreements with master netting or similar arrangements, which provide for the right of set off in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its derivative assets and liabilities subject to these arrangements on a gross basis. Please see Note 4 for information related to the Company’s repurchase agreements, which are also subject to underlying agreements with master netting or similar arrangements. The following tables present information regarding those derivative assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2026 and December 31, 2025:

			Offsetting of Assets
($s in thousands)			Gross Amount of Recognized Assets						Gross Amount Offset in the Balance Sheet						Net Amount of Assets Presented in the Balance Sheet						Gross Amount Not Offset in the Balance Sheet (1)												Net Amount
																					Financial Instruments Received as Collateral						Cash Received as Collateral
March 31, 2026
TBA securities			$	695					$	—					$	695					(557)						$	—					$	138
Derivative assets			$	695					$	—					$	695					$	(557)					$	—					$	138
December 31, 2025
Options on U.S. Treasury futures			$	2,657					$	—					$	2,657					$	—					$	—					$	2,657
TBA securities			7,841						—						7,841						(689)						(6,333)						819
Derivative assets			$	10,498					$	—					$	10,498					$	(689)					$	(6,333)					$	3,476

			Offsetting of Liabilities
($s in thousands)			Gross Amount of Recognized Liabilities						Gross Amount Offset in the Balance Sheet						Net Amount of Liabilities Presented in the Balance Sheet						Gross Amount Not Offset in the Balance Sheet (1)												Net Amount
																					Financial Instruments Posted as Collateral						Cash Posted as Collateral
March 31, 2026
Interest rate swaptions			$	4,380					$	—					$	4,380					$	—					$	—					$	4,380
TBA securities			9,741						—						9,741						(557)						(9,184)						—
Derivative liabilities			$	14,121					$	—					$	14,121					$	(557)					$	(9,184)					$	4,380
December 31, 2025
Interest rate swaptions			$	4,045					$	—					$	4,045					$	—					$	—					$	4,045
TBA securities			785						—						785						(689)						(96)						—
Derivative liabilities			$	4,830					$	—					$	4,830					$	(689)					$	(96)					$	4,045

(1)Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically, and the total cash pledged or received as collateral which is disclosed as “cash collateral posted to/by counterparties.”

18

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 – FAIR VALUE OF FINANCIAL INSTRUMENTS 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is based on the assumptions market participants would use when pricing an asset or liability and also considers all aspects of nonperformance risk, including the entity’s own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

•Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

•Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.

•Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

The following table presents the Company’s financial instruments that are measured at fair value on the Company’s consolidated balance sheet by their valuation hierarchy levels as of the dates indicated:

($s in thousands)			March 31, 2026																								December 31, 2025
			Total						Level 1						Level 2						Level 3						Total						Level 1						Level 2						Level 3
Assets:
MBS			$	22,943,257					$	—					$	22,943,257					$	—					$	16,306,988					$	—					$	16,306,988					$	—
TBA securities (1)			695						—						695						—						7,841						—						7,841						—
Option on U.S. Treasury futures			—						—						—						—						2,657						2,657						—						—
Mortgage loans (2)			599						—						—						599						618						—						—						618
Total			$	22,944,551					$	—					$	22,943,952					$	599					$	16,318,104					$	2,657					$	16,314,829					$	618
Liabilities:
TBA securities (1)			$	9,741					$	—					$	9,741					$	—					$	785					$	—					$	785					$	—
Interest rate swaptions (3)			4,380						—						4,380						—						4,045						—						4,045						—
Total			$	14,121					$	—					$	14,121					$	—					$	4,830					$	—					$	4,830					$	—

(1)TBA securities are reflected on the consolidated balance sheet as derivative assets or liabilities at their implied fair value, net of implied cost basis. Please refer to Note 5 for additional information.

(2)Mortgage loans are included on the consolidated balance sheets as a component of other assets.

(3)Interest rate swaptions are reflected on the consolidated balance sheet as derivative assets or liabilities at their fair value, net of cost. Please refer to Note 5 for additional information.

The fair value measurements for the Company’s TBA securities and its MBS are considered Level 2 because there are substantially similar securities actively trading or for which there has been recent trading activity in their respective markets. Fair value for Agency MBS and TBA securities is based on prices received from an independent third-party pricing service. In valuing a security, the pricing service primarily uses a market approach, which uses observable prices and other relevant information that is generated by market transactions of identical or

19

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

similar securities, but may use an income approach, which uses valuation techniques such as discounted cash flow modeling. Examples of the observable inputs and assumptions used in the valuation techniques include market interest rates, credit spreads, and projected prepayment speeds, among other things. The Company reviews the prices it receives from the pricing service for reasonableness using other third-party pricing services. If the fair value of a security is not available from a third-party pricing service, the Company may estimate the fair value of the security through a variety of methods using observable market data.

The Company's mortgage loans held for investment are single-family mortgage loans, which were originated or purchased by the Company prior to 2000, and for which the Company has elected the fair value option. The fair value measurements for these mortgage loans are considered Level 3 because there has been no recent trading activity of similar instruments upon which their fair value can be measured. The fair value for these Level 3 assets is measured by discounting the estimated future cash flows derived from cash flow models using certain inputs such as the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, and expected credit losses as well as certain other relevant information. The Company used a constant prepayment rate assumption of 10%, default rate of 2%, loss severity of 20%, and a discount rate of 10% in measuring the fair value of its Level 3 assets as of March 31, 2026 and as of December 31, 2025.

The Company’s short positions in U.S. Treasury futures contracts are valued based on exchange pricing and are classified accordingly as Level 1 measurements. Interest rate swaps are valued using the daily settlement price, or fair value, determined by the clearing exchange based on a pricing model that references observable market inputs, including current benchmark rates and the forward yield curve, and thus their fair values are considered Level 2 measurements. The carrying value of the U.S. Treasury futures contracts and interest rate swaps on the Company’s consolidated balance sheets is $0 because the instruments require daily margin exchanges, which are considered by the settlement agent to represent legal settlement of the contracts on a daily basis. Please see Note 1 and Note 5 for additional information regarding the fair value of the Company’s derivative instruments.

The fair value measurement of interest rate swaptions is considered Level 2 because it is based on the fair value of the underlying interest rate swap and time remaining until its expiration and is carried on the balance sheet net of any deferred premium to be paid upon exercise or expiration. The fair value measurement of options on U.S. Treasury futures is considered Level 1 because they are valued based on closing exchange prices on these contracts. Options on U.S. Treasury futures are initially recorded on the balance sheet at the contract price paid and subsequently adjusted for changes in fair value until exercise or expiration.

The Company’s repurchase agreements are reported at cost, which approximates fair value. Given their short-term nature (less than one year) and the interest rates on outstanding amounts, which largely correspond to prevailing rates observed in the repurchase agreement market, their inputs are considered Level 2.

NOTE 7 – SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION

Preferred Stock. The Company’s Board of Directors has designated 6,600,000 shares of the Company’s preferred stock for issuance as Series C Preferred Stock, of which the Company has 4,460,000 of such shares outstanding as of March 31, 2026. The Series C Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless redeemed, repurchased, or converted into common stock pursuant to the terms of the Series C Preferred Stock. As of April 15, 2025, the Series C Preferred Stock may be redeemed at any time and from time to time at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. In addition, the Series C Preferred Stock will now pay a quarterly cumulative cash dividend at a percentage of its $25.00 liquidation value per share equal to 3-month term SOFR plus the statutorily prescribed tenor spread adjustment of 0.26161% in addition to the spread pursuant to the terms of the Series C Preferred Stock of 5.461% for a total spread of 5.723%. The Company paid a quarterly dividend of $0.58711 per share of Series C Preferred Stock on April 15, 2026 to shareholders of record as

20

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

of April 1, 2026.

Common Stock. During the three months ended March 31, 2026, the Company issued 32,101,365 shares of its common stock through its at-the-market (“ATM”) program at an aggregate value of $442 million, net of broker commissions and fees. The Company declared monthly dividends on its common stock totaling $0.51 for the three months ended March 31, 2026. The Company’s timing, frequency, and amount of dividends declared on its common stock are determined by its Board of Directors. When declaring dividends, the Board of Directors considers the Company’s taxable income, management’s view on long-term returns, the REIT distribution requirements of the Tax Code, and maintaining compliance with dividend requirements of the Series C Preferred Stock, along with other factors that the Board of Directors may deem relevant from time to time.

Share-Based Compensation. The following table presents a rollforward of share-based awards for the periods indicated:

						Three Months Ended
						March 31,
						2026												2025
Type of Award						Shares						Weighted Average Grant Date Fair Value  Per Share						Shares						Weighted Average Grant Date Fair Value  Per Share
Restricted stock:
Awards outstanding, beginning of period						25,105						$	12.34					93,595						$	12.78
Granted						—						—						—						—
Vested						(16,265)						12.25						(28,792)						13.42
Awards outstanding, end of period						8,840						$	12.50					64,803						$	12.50
Target RSUs: (1)
Awards outstanding, beginning of period						738,223						$	12.79					463,070						$	12.64
Granted						428,123						13.67						152,870						14.06
Vested						(213,496)						12.66						(125,948)						12.77
Awards outstanding, end of period						952,850						$	13.21					489,992						$	13.05
Target PSUs: (2)
Awards outstanding, beginning of period						693,414						$	12.26					482,409						$	12.32
Granted						590,231						13.68						—						—
Vested						—						—						—						—
Awards outstanding, end of period						1,283,645						$	12.91					482,409						$	12.32

(1)The number of RSUs shown represent the target number of awards. Actual number of shares that will potentially settle may range from 0% if the recipient’s service-based vesting condition is not met to 100% if the service-based vesting condition is met.

(2)The number of PSUs shown represent the target number of awards. Actual number of shares that will potentially settle may range from 0% to 200% based on the achievement of the performance goals defined in each grant award.

Restricted stock granted to employees generally vests in equal installments over a period of 3 years. RSUs generally vest in equal installments over a period of 3 years if granted to employees and one year if granted to a non-employee director. PSUs cliff vest based on performance results measured over a period of 3 years. The Company expects 130% of the remaining target PSUs outstanding as of March 31, 2026 will be settled on their vesting dates.

21

---

DYNEX CAPITAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The following table discloses the dividends payable to the Company’s shareholders for common and preferred stock as well as to its employees and directors for DERs related to its outstanding RSUs and PSUs as of the dates indicated:

Dividends Payable						March 31, 2026						December 31, 2025
($s in thousands)
RSU DERs						$	1,343					$	1,578
PSU DERs						3,158						3,423
Accrued DERs						4,501						5,001
Common stock dividends						$	35,181					$	29,877
Preferred stock dividends						2,211						2,293
Accrued dividends						37,392						32,170
Total dividends payable						$	41,893					$	37,171

Total share-based compensation expense recognized by the Company for the three months ended March 31, 2026 was $8 million compared to $2 million for the three months ended March 31, 2025. The following table discloses the Company’s remaining compensation expense related to stock awards it has granted as of March 31, 2026, which will be amortized over the period disclosed:

			March 31, 2026
($s in thousands)			Remaining Compensation Cost						WAVG Period of Recognition
Restricted stock			$	100					0.9 years
RSUs			6,733						5.0 years
PSUs			6,935						2.3 years
Total			$	13,768					3.6 years

NOTE 8 - SEGMENT REPORTING

The Company’s operations consist of one reportable segment which involves investing in MBS and funding these investments with repurchase agreements and equity. Because the Company’s investment portfolio and financings are subject to market risks, primarily interest rate risk, management seeks to offset a portion of its market value exposure and financing costs through its interest rate derivative instruments (“hedging portfolio”). The Company’s investment and hedging portfolios are managed together.

The Company’s revenue is derived from its investment portfolio, which currently consists of primarily Agency RMBS. The Company’s chief operating decision maker (“CODM”) is its Co-CEO and President. Segment performance is measured by and resource allocation decisions are based on “comprehensive income (loss) to common shareholders.” The segment’s significant expense categories as shown on the Company’s consolidated statement of comprehensive income are regularly provided to the CODM for review and are also used to make resource allocation decisions. Segment assets are total assets as shown on the Company’s consolidated balance sheet.

NOTE 9 - SUBSEQUENT EVENTS

Subsequent to March 31, 2026, the Company issued 8 million shares of its common stock through its ATM program, for which it received proceeds of approximately $103 million, net of commissions.

22

---

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

During the first quarter of 2026, financial markets experienced increased volatility as investors reassessed the outlook for inflation, monetary policy, and global growth amid heightened geopolitical uncertainty. While the U.S. economy continued to expand at a moderate pace, uncertainty around the inflation trajectory led market participants to reduce expectations for near‑term Federal Reserve policy easing. Funding markets remained orderly, and liquidity across the mortgage and repo markets continued to function effectively. Spreads across Agency MBS widened meaningfully, particularly late in the quarter, as periodic correlation with risky assets increased amid macroeconomic and geopolitical developments.

Against this backdrop, Agency MBS continues to offer attractive long‑term return potential relative to other high‑quality fixed‑income assets, particularly given muted new mortgage origination supply and the sector’s strong liquidity profile. We continue to monitor monetary policy, inflation trends, housing market activity, supply‑and‑demand dynamics, and geopolitical developments, as we assess their potential impact on interest rates, spreads, prepayment behavior, and financing conditions. We remain focused on disciplined portfolio construction, liquidity management, and risk positioning as market conditions continue to evolve.

The charts below show the range of U.S. Treasury and Secured Overnight Funding Rate (“SOFR”)-based swap rates for the three months ended March 31, 2026 and information regarding market spreads as of and for the periods indicated:

23

---

						Market Spreads as of:												Change in Spreads YTD
Investment Type: (1)						March 31, 2026																											December 31, 2025
Agency RMBS:
2.0% coupon						73																								70						3
2.5% coupon						76																								73						3
4.0% coupon						52																								50						2
4.5% coupon						53																								45						8
5.0% coupon						56																								46						10
5.5% coupon						63																								51						12
6.0% coupon						64																								54						10
Agency CMBS(2)						84																								82						2

(1)Option adjusted spreads (“OAS”) are based on Company estimates using third-party models and market data. OAS shown for prior periods may differ from previous disclosures because the Company regularly updates the third-party model used.

(2)Data is sourced from J.P. Morgan and represents the spread to swap rate on newly issued Agency securities collateralized by multifamily properties.

Summary of First Quarter 2026 Financial Performance

For the first quarter of 2026, our total economic return of $(0.34) per common share was comprised of a decrease in book value of $(0.85) per common share offset by dividends declared of $0.51 per common share. The decrease in book value per common share was driven by a net loss of $(140) million on our investment portfolio, net of hedges, which resulted primarily from widening mortgage spreads late in the quarter. We grew our capital base by $442 million, using the proceeds to opportunistically add investments of $6 billion, net of sales. Our adjusted leverage increased to 8.6 times equity primarily due to our use of repurchase agreement borrowings to partially finance these purchases.

Our interest income continued to increase as a result of our deployment of capital into Agency MBS purchases over recent quarters. In addition, the Federal Reserve's rate cuts in 2025 continued to benefit our repurchase agreement financing costs, which declined 33 basis points for the first quarter of 2026 compared to the prior quarter. Operating expenses for the first quarter of 2026 included an increase of $3.4 million in share-based compensation expense, largely due to accelerated vesting conditions for equity grants associated with the departure of the Company's former chief financial officer.

24

---

The following table summarizes the changes in the Company's financial position during the three months ended March 31, 2026:

($s in thousands except per share data)			Net Change in Fair Value						Components of Comprehensive Income						Common Book Value Rollforward						Per Common Share
Balance as of December 31, 2025 (1)															$	2,350,644					$	13.45
Net interest income									$	79,254
Periodic interest from interest rate swaps									1,698
G & A and other operating expenses									(21,253)
Preferred stock dividends									(2,658)
Changes in fair value:
MBS and other			$	(243,238)
TBAs			(13,879)
U.S. Treasury futures			35,308
Options on U.S. Treasury futures			(2,656)
Interest rate swaps			84,591
Interest rate swaptions			(335)
Total net change in fair value									(140,209)
Comprehensive loss to common shareholders															(83,168)
Capital transactions:
Net proceeds from stock issuance (2)															446,903
Common dividends declared															(104,609)
Balance as of March 31, 2026 (1)															$	2,609,770					$	12.60

(1)Amounts represent total shareholders' equity less the aggregate liquidation preference of the Company's preferred stock of $111.5 million, in thousands and on a per common share basis.

(2)Net proceeds from common stock issuance include approximately $442 million from ATM issuances and approximately $5 million from amortization of share-based compensation, net of grants, during the three months ended March 31, 2026.

25

---

FINANCIAL CONDITION

Investment Portfolio

Our investment portfolio, including TBAs, as of March 31, 2026, has increased $6 billion, or 27%, since December 31, 2025, net of sales. We added over $7 billion of Agency RMBS, net of sales of $608 million, during the three months ended March 31, 2026. We reduced our TBA securities by a net notional of $1.3 billion. The following charts compare the composition of our investment portfolio as of the dates indicated:

The following tables compare our 30-year fixed-rate Agency RMBS investments, including TBA dollar roll positions, as of the dates indicated:

						March 31, 2026
Agency RMBS by Coupon						Par/Notional						Amortized Cost/ Implied Cost Basis (3)(5)						Fair Value (4)(5)						Weighted Average
																								Loan Age (in months)(6)						3 Month CPR (6)(7)						Estimated Duration (8)						Market Yield (9)
($s in thousands)
2.0%						$	1,275,957					$	1,164,966					$	1,041,759					68						2.2		%				7.43						4.75		%
2.5%						648,281						646,466						554,603						65						4.6		%				6.97						4.76		%
4.0%						286,550						286,876						272,829						60						6.4		%				5.86						4.81		%
4.5% (1)						1,685,062						1,636,907						1,636,567						36						6.7		%				5.51						4.96		%
5.0%						7,479,116						7,434,011						7,420,134						13						3.9		%				5.01						5.11		%
5.5%						9,038,565						9,145,191						9,152,542						12						8.4		%				3.83						5.28		%
6.0%						1,494,282						1,537,251						1,538,780						11						14.8		%				2.72						5.40		%
TBA 4.5%(2)						1,257,000						1,230,544						1,227,574						n/a						n/a						4.63						4.90		%
TBA 5.0%						603,000						600,548						594,473						n/a						n/a						4.91						5.20		%
Total						$	23,767,813					$	23,682,760					$	23,439,261					19						6.8		%				4.59						5.15		%

						December 31, 2025
Agency RMBS by Coupon						Par/Notional						Amortized Cost/ Implied Cost Basis (3)(5)						Fair Value (4)(5)						Weighted Average
																								Loan Age (in months)(6)						3 Month CPR (6)(7)						Estimated Duration (8)						Market Yield (9)
($s in thousands)
2.0%						$	603,965					$	613,475					$	497,097					63						5.2		%				7.42						4.68		%
2.5%						516,325						535,039						444,904						64						5.1		%				7.02						4.67		%
4.0%						293,073						293,432						281,889						57						6.5		%				5.89						4.63		%
4.5% (1)						1,911,130						1,853,757						1,881,304						33						5.8		%				5.46						4.74		%
5.0%						3,974,655						3,913,622						3,997,537						21						5.9		%				4.62						4.91		%
5.5%						6,325,638						6,361,758						6,465,769						13						8.1		%				3.39						5.10		%
6.0%						1,381,567						1,419,727						1,432,860						9						8.2		%				2.28						5.14		%
TBA 4.0%						1,162,000						1,101,441						1,102,764						n/a						n/a						6.29						4.76		%
TBA 4.5%(2)						1,447,000						1,425,945						1,430,136						n/a						n/a						4.58						4.64		%
TBA 5.0%						176,000						175,287						175,670						n/a						n/a						4.51						5.03		%
TBA 5.5%						183,000						185,175						185,631						n/a						n/a						3.28						5.23		%
TBA 6.0%						221,000						226,218						226,922						n/a						n/a						1.99						5.24		%
Total						$	18,195,353					$	18,104,876					$	18,122,483					21						7.0		%				4.29						4.94		%

(1)Includes a par value of $9 million of 4.5% 15-year Agency RMBS as of March 31, 2026 and December 31, 2025.

(2)Includes a notional amount of $540 million of 4.5% 15-year TBA securities as of March 31, 2026 and $690 million as of December 31, 2025.

(3)Implied cost basis of TBAs represents the forward price to be paid for the underlying Agency MBS.

(4)Fair value of TBAs is the implied market value of the underlying Agency security as of the end of the period.

(5)TBAs are included on the consolidated balance sheet within “derivative assets/liabilities” at their net carrying value which is the difference between their implied market value and implied cost basis. Please refer to Note 5 of the Notes to the Consolidated Financial Statements for additional information.

(6)TBAs are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.

(7)Constant prepayment rate (“CPR”) represents the 3-month CPR of Agency RMBS held as of date indicated.

(8)Duration measures the sensitivity of a security's price to the change in interest rates and represents the percent change in price of a security for a 100-basis point increase in interest rates. We calculate duration using third-party financial models and empirical data. Different models and methodologies can produce different estimates of duration for the same securities.

(9)Represents the weighted average market yield projected using cash flows generated from the forward curve based on market prices as of the date indicated and assuming zero volatility.

Our Agency CMBS consist of loans collateralized by multifamily properties. Though we expect our exposure to Agency CMBS to remain modest as a percentage of the total portfolio, we will add Agency CMBS from time to time whenever we believe the risk-adjusted return profile aligns with our investment strategy. In addition to offering strong relative value, Agency CMBS help diversify and stabilize the portfolio's cash flow and total return profile, given their unique prepayment characteristics and underlying asset base.

Agency CMBS IO are backed by loans collateralized by multifamily properties. Our Agency CMBS IO are from Freddie Mac Series K deals from which interest continues to be advanced even in the event of an underlying default up until liquidation. Our non-Agency CMBS IO were all originated prior to 2018 and are backed by loans collateralized by a number of different property types, such as multifamily, office, retail, hotels, industrial, storage, and others. Our non-Agency CMBS IO investments are nearing maturity and have very little amortized cost remaining; any changes in actual payments may result in large swings in yield as shown below.

The following table provides certain information regarding our CMBS and CMBS IO as of the dates indicated:

			March 31, 2026
($s in thousands)			Par/Notional Value						Amortized Cost						Fair Value						WAVG Life Remaining (1)						WAVG Market Yield (2)
Agency CMBS			$	1,244,753					$	1,246,548					$	1,244,801					5.5						4.37		%
CMBS IO			5,790,816						81,484						81,242						4.6						7.21		%
Total									$	1,328,032					$	1,326,043
			December 31, 2025
($s in thousands)			Par/Notional Value						Amortized Cost						Fair Value						WAVG Life Remaining (1)						WAVG Market Yield (2)
Agency CMBS			$	1,210,953					$	1,213,107					$	1,218,343					5.5						4.25		%
CMBS IO			6,000,525						87,557						87,285						4.7						10.40		%
Total									$	1,300,664					$	1,305,628
(1) Represents the weighted average life remaining in years based on contractual cash flows as of the dates indicated.
(2) Represents the weighted average market yield projected using cash flows generated off the forward curve based on market prices as of the dates indicated and assuming zero volatility.

Repurchase Agreements

Our repurchase agreement borrowings increased to $21 billion as of March 31, 2026 from $14 billion as of December 31, 2025. These borrowings were used to partially finance our purchases of Agency MBS during the three months ended March 31, 2026. We have not experienced any difficulty in securing financing with any of our counterparties, and our repurchase agreement counterparties have not indicated any concerns regarding leverage or credit. Please refer to Note 4 of the Notes to the Consolidated Financial Statements contained within this Quarterly Report on Form 10-Q as well as “Results of Operations” and “Liquidity and Capital Resources” contained within this Item 2 for additional information relating to our repurchase agreement borrowings.

Derivative Assets and Liabilities

Please refer to Note 5 of the Notes to the Consolidated Financial Statements for details on our interest rate hedging instruments as well as “Liquidity and Capital Resources” within Item 2 and “Quantitative and Qualitative Disclosures about Market Risk” within Item 3 of this Quarterly Report on Form 10-Q.

26

---

RESULTS OF OPERATIONS

The following table summarizes the results of operations for the periods discussed in this section:

			Three Months Ended
$s in thousands			March 31, 2026						December 31, 2025						March 31, 2025
Net interest income			$	79,254					$	43,484					$	17,133
Realized gain on sales of investments, net			8,721						—						—
Unrealized (loss) gain on investments, net			(251,811)						84,732						109,997
Gain (loss) on derivative instruments, net			104,727						73,781						(118,088)
Operating expenses, net			(21,253)						(16,639)						(12,118)
Preferred stock dividends			(2,658)						(2,760)						(1,923)
Net (loss) income to common shareholders			(83,020)						182,598						(4,999)
Other comprehensive (loss) income			(148)						7,008						19,390
Comprehensive (loss) income to common shareholders			$	(83,168)					$	189,606					$	14,391

Net Interest Income for the Three Months Ended March 31, 2026 Compared to the Three Months Ended December 31, 2025

Net interest income and net interest spread for the three months ended March 31, 2026, increased compared to the three months ended December 31, 2025, due to our recent purchases of higher yielding Agency MBS. Though interest expense increased due to an increase in repurchase agreement borrowings used to finance these purchases, the average financing rate we paid declined 33 basis points over the comparative periods.

The impact of net periodic interest on our economic net interest income for the three months ended March 31, 2026, decreased approximately $6 million, or 20 basis points as a percentage of average repurchase agreement borrowings, compared to the three months ended December 31, 2025. Our weighted average net receive rate declined 29 basis points to almost 0% for the three months ended March 31, 2026.

The following table presents information about our interest-earning assets and interest-bearing liabilities and their performance for the periods indicated:

			Three Months Ended
			March 31, 2026																		December 31, 2025
($s in thousands)			Interest Income/Expense						Average Balance (1)(2)						Effective Yield/ Financing Cost (3)(4)						Interest Income/Expense						Average Balance (1)(2)						Effective Yield/ Financing Cost (3)(4)
Agency RMBS			$	236,350					$	18,926,563					5.00		%				$	158,160					$	12,712,611					4.98		%
Agency CMBS			12,530						1,177,399						4.26		%				9,992						915,117						4.27		%
CMBS IO (5)			1,781						84,531						8.23		%				1,484						90,573						6.25		%
Other investments			6						461						3.98		%				7						769						3.22		%
Subtotal			$	250,667					$	20,188,954					4.97		%				$	169,643					$	13,719,070					4.94		%
Cash equivalents			6,723																		7,393
Total interest income			$	257,390																	$	177,036
Repurchase agreement financing			(178,136)						18,470,997						(3.86)		%				(133,552)						12,469,902						(4.19)		%
Net interest income (expense)/spread			$	79,254											1.11		%				$	43,484											0.75		%
Net periodic interest (6)			1,698												0.04		%				7,598												0.24		%
Economic net interest income (expense)/spread (6)			$	80,952											1.15		%				$	51,082											0.99		%
*Table Note: Data may not foot due to rounding.

(1)Average balance for assets is calculated as a simple average of the daily amortized cost and excludes securities pending settlement if applicable.

(2)Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.

(3)Effective yield is calculated by dividing interest income by the average balance of asset type outstanding during the reporting period. Unscheduled adjustments to premium/discount amortization/accretion, such as for prepayment compensation, are not annualized in this calculation.

(4)Financing cost is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.

(5)Includes Agency and non-Agency issued securities.

(6)Net periodic interest is the difference between the fixed interest rate we pay and the variable interest rate we receive on our interest rate swaps. It is a component of economic net interest income (expense), a non-GAAP measure. Please refer to the section below “Non-GAAP Financial Measures” for more information.

Net Interest Income for the Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025

Net interest income and net interest spread increased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025 due to the purchases of higher yielding Agency MBS over the past year. Though interest expense increased due to an increase in repurchase agreement borrowings used to finance these purchases, the average financing rate we paid declined 70 basis points over the comparative periods primarily as a result of the Federal Reserve’s rate cuts since first quarter of 2025.

The impact of net periodic interest on our economic net interest income for the three months ended March 31, 2026, decreased over $9 million, or 60 basis points as a percentage of average repurchase agreement borrowings, compared to the three months ended March 31, 2025. Our weighted average net receive rate declined 68 basis points to almost 0% for the three months ended March 31, 2026.

The following table presents information about our interest-earning assets and interest-bearing liabilities and their performance for the periods indicated:

			Three Months Ended
			March 31,
			2026																		2025
($s in thousands)			Interest Income/Expense						Average Balance (1)(2)						Effective Yield/ Financing Cost (3)(4)						Interest Income/Expense						Average Balance (1)(2)						Effective Yield/ Financing Cost (3)(4)
Agency RMBS			$	236,350					$	18,926,563					5.00		%				$	90,075					$	7,726,081					4.66		%
Agency CMBS			12,530						1,177,399						4.26		%				735						86,880						3.38		%
CMBS IO (5)			1,781						84,531						8.23		%				2,332						113,263						8.74		%
Other investments			6						461						3.98		%				14						999						4.96		%
Subtotal			$	250,667					$	20,188,954					4.97		%				$	93,156					$	7,927,223					4.71		%
Cash equivalents			6,723																		1,903
Total interest income			$	257,390																	$	95,059
Repurchase agreement financing			(178,136)						18,470,997						(3.86)		%				(77,926)						6,842,485						(4.56)		%
Net interest income/spread			$	79,254											1.11		%				$	17,133											0.15		%
Net periodic interest (6)			1,698												0.04		%				10,851												0.64		%
Economic net interest income/spread (6)			$	80,952											1.15		%				$	27,984											0.79		%
*Table Note: Data may not foot due to rounding.

(1)Average balance for assets is calculated as a simple average of the daily amortized cost and excludes securities pending settlement if applicable.

(2)Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.

(3)Effective yield is calculated by dividing interest income by the average balance of asset type outstanding during the reporting period. Unscheduled adjustments to premium/discount amortization/accretion, such as for prepayment compensation, are not annualized in this calculation.

(4)Financing cost is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.

(5)Includes Agency and non-Agency issued securities.

(6)Net periodic interest is the difference between the fixed interest rate we pay and the variable interest rate we receive on our interest rate swaps. It is a component of economic net interest income (expense), a non-GAAP measure. Please refer to the section below “Non-GAAP Financial Measures” for more information.

Gains (Losses) on Investments and Derivative Instruments

For the three months ended March 31, 2026, losses on our investment portfolio exceeded gains on our hedges by approximately $(139) million, which includes $2 million in net periodic interest we earned from interest rate swaps. The fair value of our investment portfolio declined $(257) million during the three months ended March 31, 2026 primarily due to widening of mortgage spreads to U.S. Treasuries. The impact of higher U.S. Treasury rates on our investments was offset by net gains on our interest rate hedges of $119 million, which also benefited from higher SOFR-based swap rates during the three months ended March 31, 2026.

For the three months ended December 31, 2025, we recorded net gains of $109 million on our investment portfolio due mostly to spread tightening on our assets. We also recorded net gains of $56 million on our interest rate hedging portfolio driven primarily from management of our interest rate swaps as rates increased during the

fourth quarter of 2025.

For the three months ended March 31, 2025, the fair value of our investment portfolio increased $171.6 million primarily due to a decline of 36 basis points in the 10-year U.S. Treasury rate. These gains were mostly offset by net losses on our hedging portfolio of $(171.1) million (excluding $10.9 million of net periodic interest we earned from our interest rate swaps), as a result of the decline in 10-year and 30-year U.S. Treasury rates as well as SOFR rates across the curve.

The following tables provide details on realized and unrealized gains and losses within our investment and interest rate hedging portfolios for the periods indicated:

						Three Months Ended
						March 31, 2026
($s in thousands)						Realized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in OCI						Total Change in Fair Value
Investment portfolio:
Agency RMBS						$	8,461					$	(244,781)					$	(224)					$	(236,544)
Agency CMBS						260						(6,981)						(2)						(6,723)
CMBS IO						—						(47)						78						31
Other investments						—						(2)						—						(2)
Subtotal						8,721						(251,811)						(148)						(243,238)
TBA securities (1)						2,223						(16,102)						—						(13,879)
Net gain on investments						$	10,944					$	(267,913)					$	(148)					$	(257,117)
Interest rate hedging portfolio:
U.S. Treasury futures						$	(1,098)					$	36,406					$	—					$	35,308
Interest rate swaps (2)						1,331						84,958						—						86,289
Interest rate swaptions						—						(335)						—						(335)
Options on U.S. Treasury futures						(3,981)						1,325						—						(2,656)
Net loss on interest rate hedges						$	(3,748)					$	122,354					$	—					$	118,606
Total net gain						$	7,196					$	(145,559)					$	(148)					$	(138,511)

						Three Months Ended
						December 31, 2025
($s in thousands)						Realized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in OCI						Total Change in Fair Value
Investment portfolio:
Agency RMBS						$	—					$	84,123					$	6,080					$	90,203
Agency CMBS						—						512						158						670
CMBS IO						—						74						770						844
Other investments						—						23						—						23
Subtotal						—						84,732						7,008						91,740
TBA securities (1)						12,486						4,806						—						17,292
Net gain on investments						$	12,486					$	89,538					$	7,008					$	109,032
Interest rate hedging portfolio:
U.S. Treasury futures						$	(37,778)					$	50,038					$	—					$	12,260
Interest rate swaps (2)						7,598						47,734						—						55,332
Interest rate swaptions						—						(3,759)						—						(3,759)
Options on U.S. Treasury futures						(6,527)						(817)						—						(7,344)
Net loss on interest rate hedges						$	(36,707)					$	93,196					$	—					$	56,489
Total net gain						$	(24,221)					$	182,734					$	7,008					$	165,521

						Three Months Ended
						March 31, 2025
($s in thousands)						Realized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in Net Income						Unrealized Gain (Loss) Recognized in OCI						Total Change in Fair Value
Investment portfolio:
Agency RMBS						$	—					$	109,260					$	16,916					$	126,176
Agency CMBS						—						110						1,126						1,236
CMBS IO						—						609						1,348						1,957
Other investments						—						18						—						18
Subtotal						—						109,997						19,390						129,387
TBA securities (1)						17,323						24,851						—						42,174
Net gain (loss) on investments						$	17,323					$	134,848					$	19,390					$	171,561
Interest rate hedging portfolio:
U.S. Treasury futures						$	(25,801)					$	(18,546)					$	—					$	(44,347)
Interest rate swaps						10,851						(127,577)						—						(116,726)
Interest rate swaptions						—						811						—						811
Net (loss) gain on interest rate hedges						$	(14,950)					$	(145,312)					$	—					$	(160,262)
Total net gain (loss)						$	2,373					$	(10,464)					$	19,390					$	11,299

(1)Realized and unrealized gains (losses) on TBA securities are recorded within “gain (loss) on derivative instruments, net” on the Company’s consolidated statements of comprehensive income.

(2)Realized gain for interest rate swaps consists of net periodic interest benefit of $1.7 million for the three months ended March 31, 2026, $7.6 million for the three months ended December 31, 2025, and $10.9 million for the three months ended March 31, 2025.

We hold long and short positions in TBA securities by executing a series of transactions, commonly referred to as “dollar roll” transactions, which effectively delay the settlement of a forward purchase (or sale) of a non-specified Agency RMBS by entering into an offsetting TBA position, net settling the paired-off positions in cash, and simultaneously entering into an identical TBA long (or short) position with a later settlement date. TBA securities purchased or sold for a forward settlement date are generally priced at a discount relative to TBA securities settling in the current month because the current month settlement will receive a coupon sooner than the TBA settling in a forward month. This price difference, often referred to as “drop income,” represents the economic equivalent of net interest income (interest income less implied financing cost) on the underlying Agency security from the trade date to the settlement date. We account for all TBAs (whether net long or net short positions, or collectively “TBA dollar roll positions”) as derivative instruments because we cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS, or that the individual TBA transaction will settle in the shortest period possible.

The following table presents information regarding the performance of our TBA dollar roll transactions for the periods indicated:

						Three Months Ended
						March 31, 2026																		December 31, 2025
($s in thousands)						Implied Net Interest Income (1)						Average Balance						Implied Net Spread						Implied Net Interest Expense (1)						Average Balance						Implied Net Spread
TBAs						$	4,764					$	1,997,823					0.95		%				$	2,716					$	2,446,336					0.44		%
																								Three Months Ended
																								March 31, 2025
																								Implied Net Interest Expense (1)						Average Balance						Implied Net Spread
TBAs																								$	4,785					$	2,400,084					0.80		%

(1)Implied net interest income (expense) is also referred to as “drop income (loss)” and represents a portion of the total realized gain (loss) from our TBA dollar roll transactions recorded within “gain (loss) on derivative instruments, net.”

Operating Expenses

Operating expenses for the three months ended March 31, 2026 increased $5 million compared to the three months ended December 31, 2025 and $9 million compared to the three months ended March 31, 2025. In addition to higher salary and share-based compensation expenses resulting from new employees, operating expenses also increased due to accelerated vesting of equity grants and other severance expenses associated with the departure of the Company's former chief financial officer.

Non-GAAP Financial Measures

In addition to reporting the Company’s financial results determined in accordance with GAAP, management of the Company believes that investors’ understanding of our operating results may be enhanced by the use of non-GAAP financial measures, which are used by management internally, along with GAAP measures, to evaluate our performance. Our non-GAAP financial measures include earnings available for distribution (“EAD”) to common shareholders (including per common share) and economic net interest income and the related metric economic net interest spread. Management believes these non-GAAP financial measures may be useful to investors because they are viewed by management as additional measures of the investment portfolio’s return.

Drop income generated by TBA dollar roll positions, which is included in "gain (loss) on derivatives instruments, net" on the Company's consolidated statements of comprehensive income, is included in EAD because management views drop income as the economic equivalent of net interest income (interest income less implied

financing cost) on the underlying Agency security from trade date to settlement date. However, drop income does not represent the total realized gain/loss from the Company’s investments in TBA securities.

Management also includes net periodic interest from its interest rate swaps, which is included in "gain (loss) on derivatives instruments, net," in EAD and economic net interest income because interest rate swaps are used by the Company to economically hedge the impact of changing interest rates on its borrowing costs from repurchase agreements, and including net periodic interest from interest rate swaps is a helpful indicator of the Company’s total financing cost in addition to GAAP interest expense.

Non-GAAP financial measures are not a substitute for GAAP measures and may be different from non-GAAP measures used by other companies. In addition, other companies, including in our industry, may calculate comparable measures differently, which reduces their usefulness as comparative measures. Investors should not rely on any single financial measure when evaluating our business. These non-GAAP measures should be considered as supplemental in nature and not as a substitute for our operating results in accordance with GAAP.

Reconciliations of each non-GAAP measure to certain GAAP financial measures are provided below.

						Three Months Ended
Reconciliations of GAAP to Non-GAAP Financial Measures:						March 31, 2026						December 31, 2025
($s in thousands except per share data)
Comprehensive (loss) income to common shareholders (GAAP)						$	(83,168)					$	189,606
Less:
Change in fair value of investments (1)						243,238						(91,740)
Change in fair value of derivative instruments, net (2)						(98,266)						(63,467)
EAD to common shareholders (non-GAAP)						$	61,804					$	34,399
Average common shares outstanding						200,084,349						156,041,438
EAD per common share (non-GAAP)						$	0.31					$	0.22
Net interest income (GAAP)						$	79,254					$	43,484
Net periodic interest earned from interest rate swaps						1,698						7,598
Economic net interest income (non-GAAP)						80,952						51,082
TBA drop income (3)						4,763						2,716
Total operating expenses						(21,253)						(16,639)
Preferred stock dividends						(2,658)						(2,760)
EAD to common shareholders (non-GAAP)						$	61,804					$	34,399
Net interest spread (GAAP)						1.11		%				0.75		%
Net periodic interest from interest rate swaps as a percentage of average repurchase borrowings						0.04		%				0.24		%
Economic net interest spread (non-GAAP)						1.15		%				0.99		%

(1)Amount includes realized and unrealized gains and losses due to changes in the fair value of the Company’s MBS.

(2)The following table reconciles “change in fair value of derivative instruments, net” to the “gain (loss) on derivative instruments, net” shown on the consolidated statements of comprehensive income.

			Three Months Ended
($s in thousands)			March 31, 2026						December 31, 2025
Gain on derivative instruments, net			$	104,727					$	73,781
Less:
TBA drop income			(4,763)						(2,716)
Net periodic interest earned from interest rate swaps			(1,698)						(7,598)
Change in fair value of derivative instruments, net			$	98,266					$	63,467

(3)TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates.

LIQUIDITY AND CAPITAL RESOURCES

 Our primary sources of liquidity include borrowings under repurchase arrangements and monthly principal and interest payments we receive on our investments. Additional sources may include proceeds from the sale of investments, equity offerings, and net payments received from counterparties for derivative instruments. We use our liquidity to purchase investments, to pay amounts due on our repurchase agreement borrowings, and to pay our operating expenses and dividends on our common and preferred stock. We also use our liquidity to meet margin requirements for our repurchase agreements and derivative transactions, including TBA contracts, under the terms of the related agreements. We may also periodically use liquidity to repurchase shares of the Company’s stock.

During the three months ended March 31, 2026, we issued 32,101,365 shares of common stock through our ATM program, resulting in proceeds of $0.4 billion, net of broker commissions and fees. We deployed these proceeds into purchases of Agency RMBS.

Our liquidity fluctuates based on our investment activities, leverage, capital raising activities, and changes in the fair value of our investments and derivative instruments. Our measurement of liquidity includes unrestricted cash and cash equivalents and unpledged Agency MBS, which are recognized as assets on our consolidated balance sheet. In our measure of liquidity, we also include the fair value of noncash collateral pledged to us by our counterparties, which we typically receive when the fair value of our pledged collateral exceeds our current margin requirement. Our liquidity as of March 31, 2026, was approximately $1.3 billion, which consisted of unrestricted cash of $773 million and unpledged Agency MBS with a fair value of $478 million. Our liquidity was $1.4 billion as of December 31, 2025.

We continuously monitor our liquidity, especially with potential risk events on the horizon, such as tariff changes, potential GSE transition, uncertainty regarding Federal Reserve policy decisions, the size of the Federal Reserve’s balance sheet, quantitative tightening or easing measures, federal government shutdowns, and the impact on global markets stemming from global central bank policies. We are also monitoring the wars and conflicts around the globe. We continuously assess the adequacy of our liquidity under various scenarios based on changes in the fair value of our investments and derivative instruments due to market factors such as changes in the absolute level of interest rates and the shape of the yield curve, credit spreads, lender haircuts, and prepayment speeds, which in turn have an impact on margin requirements. In performing these analyses, we also consider the current state of the fixed-income markets and the repurchase agreement markets to determine if market forces such as supply-demand imbalances or structural changes to these markets could change the liquidity of MBS or the availability of financing. We have not experienced any material changes in the terms of our repurchase agreements with our counterparties, and they have not indicated to us any concerns regarding access to liquidity.

In addition to the GSE guarantee of principal payments on our Agency investments, we expect the capital and repurchase agreement markets will remain accessible at capacities sufficient to cover our short-term and long-term liquidity needs.

Our perception of the liquidity of our investments and market conditions significantly influences our targeted leverage. In general, our leverage will increase if we view the risk-reward opportunity of higher leverage on

our capital outweighs the risk to our liquidity and book value. Our leverage, which we calculate using total liabilities plus the cost basis of TBA long positions, was 8.6 times shareholders’ equity as of March 31, 2026. We include 100% of the cost basis of our TBA securities in evaluating our leverage because it is possible under certain market conditions that it may be uneconomical for us to roll a TBA long position into future months, which may result in us having to take physical delivery of the underlying securities and use cash or other financing sources to fund our total purchase commitment.

Repurchase Agreements

Leverage based solely on repurchase agreement amounts outstanding was 7.7 times shareholders’ equity as of March 31, 2026. Our repurchase agreement borrowings are uncommitted with terms renewable at the discretion of our lenders and generally have original terms to maturity of overnight to six months, though in some instances, we may enter into longer-dated maturities depending on market conditions. We seek to maintain unused capacity under our existing repurchase agreement credit lines with multiple counterparties, which helps protect us in the event of a counterparty's failure to renew existing repurchase agreements. As part of our continuous evaluation of counterparty risk, we maintain our highest counterparty exposures with broker-dealer subsidiaries of regulated financial institutions or primary dealers.

The amount outstanding for our repurchase agreement borrowings will typically fluctuate in any given period as it is dependent upon several factors, but particularly the extent to which we are active in buying and selling securities, including the volume of activity in TBA dollar roll transactions versus buying specified pools. The following table presents information regarding the balances of our repurchase agreement borrowings as of and for the periods indicated:

			Repurchase Agreements
($s in thousands)			Balance Outstanding As of Quarter End						Average Balance Outstanding For the Quarter Ended						Maximum Balance Outstanding During the Quarter Ended
March 31, 2026			$	21,045,457					$	18,470,997					$	21,045,636
December 31, 2025			13,904,231						12,469,902						13,904,304
September 30, 2025			11,753,522						10,468,568						11,754,581
June 30, 2025			8,600,143						7,871,627						8,600,487
March 31, 2025			7,234,723						6,842,485						7,234,723

For our repurchase agreement borrowings, we are required to post and maintain margin to the lender (i.e., collateral in excess of the repurchase agreement borrowing) in order to support the amount of the financing. This excess collateral is often referred to as a “haircut” and is intended to provide the lender protection against fluctuations in the fair value of the collateral and/or the failure by us to repay the borrowing at maturity. Lenders have the right to change haircut requirements at maturity of the repurchase agreement and may change their haircuts based on market conditions and the perceived riskiness of the collateral pledged. If the fair value of the collateral falls below the amount required by the lender, the lender has the right to demand additional margin or collateral. If we fail to meet any margin call, our lenders have the right to terminate the repurchase agreement and sell any collateral pledged. The weighted average haircut for our borrowings as of March 31, 2026, was consistent with prior periods, typically averaging less than 5% for borrowings collateralized with Agency RMBS and CMBS and between 10-14% for borrowings collateralized with CMBS IO.

The collateral we post in excess of our repurchase agreement borrowing with any counterparty is also typically referred to by us as “equity at risk,” which represents the potential loss to the Company if the counterparty is unable or unwilling to return collateral securing the repurchase agreement borrowing at its maturity. The counterparties with whom we have the greatest amounts of equity at risk may vary significantly during any given period due to the short-term and uncommitted nature of the repurchase agreement borrowings. As of March 31, 2026, we had amounts outstanding with over 25 counterparties and did not have more than 10% of equity at risk with any counterparty or group of related counterparties.

We have various financial and operating covenants in certain of our repurchase agreements, which we monitor and evaluate on an ongoing basis for compliance as well as for impacts these customary covenants may have on our operating and financing flexibility. We do not believe we are subject to any covenants that materially restrict our financing flexibility. We were in full compliance with our debt covenants as of March 31, 2026, and we are not aware of circumstances that could potentially result in our non-compliance in the near future.

Derivative Instruments

Derivative instruments we enter into may require us to post initial margin at inception and daily variation margin based on subsequent changes in their fair value. Daily variation margin requirements also entitle us to receive collateral from our counterparties if the value of amounts owed to us under the derivative agreement exceeds the minimum margin requirement. The collateral posted as margin by us is typically in cash. As of March 31, 2026, we had cash collateral posted to our counterparties of $517 million under these agreements.

Collateral requirements for interest rate derivative instruments are typically governed by the central clearing exchange and the associated futures commission merchant, which may establish margin requirements in excess of the clearing exchange. Collateral requirements for our TBA contracts are governed by the Mortgage-Backed Securities Division (“MBSD”) of the Fixed Income Clearing Corporation and, if applicable, by our third-party brokerage agreements, which may establish margin levels in excess of the MBSD. Our TBA contracts, which are subject to master securities forward transaction agreements published by the Securities Industry and Financial Markets Association as well as supplemental terms and conditions with each counterparty, generally provide that valuations for our TBA contracts and any pledged collateral are to be obtained from a generally recognized source agreed to by both parties. However, in certain circumstances, our counterparties have the sole discretion to determine the value of the TBA contract and any pledged collateral. In such instances, our counterparties are required to act in good faith in making determinations of value. In the event of a margin call, we must generally provide additional collateral on the same business day.

The following table provides details on the “net (payments) receipts on derivative instruments” shown on our consolidated statements of cash flows for the periods indicated:

						Three Months Ended
						March 31,
Cash received or paid by instrument:						2026						2025
						($s in thousands)
Interest rate swaps:
Net variation margin (paid) received						$	115,912					$	(109,360)
Paid upon maturity/termination						(367)						—
Net periodic interest (1)						1,225						—
						116,770						(109,360)
U.S. Treasury futures:
Net variation margin received (paid)						48,720						(11,482)
Paid upon maturity/termination						(1,098)						(25,801)
						47,622						(37,283)
TBA securities:
Received upon settlement						4,650						9,608
Net receipts (payments) on derivative instruments						$	169,042					$	(137,035)

(1)Net periodic interest from our effective interest rate swaps is recognized as income or expense during the period earned or incurred, but the cash is not received or paid until the anniversary of each agreement’s effective date or upon maturity.

Dividends

We set our dividend based on many factors, including our view on long-term returns, yield on comparable investments, liquidity and market risk, and taxable income. Among these factors, we focus on economic returns and taxable income within the context of the distribution requirements. As a REIT, we are required to distribute to our shareholders amounts equal to at least 90% of our REIT taxable income for each taxable year after certain deductions, including the separate dividend requirements of the Series C Preferred Stock. 

We designate certain derivative instruments as interest rate hedges for tax purposes. Realized gains (losses) resulting from the difference in fair value and the amount of cash received or paid upon termination or maturity of designated derivative instruments are included in GAAP earnings in the same reporting period in which the derivative instrument matures or is terminated by the Company but are generally not recognized in REIT taxable income until future periods. Non-designated derivative instruments are included in GAAP earnings and REIT taxable income in the same period the derivative instrument matures or is terminated by the Company. The table below provides the projected amortization of the Company's net deferred tax hedge gains that may be recognized as taxable income over the periods indicated, given conditions known as of March 31, 2026; however, uncertainty inherent in the forward interest rate curve makes future realized gains and losses difficult to estimate, and as such, these projections are subject to change for any given period.

Projected Period of Recognition for Tax Hedge Gains, Net						March 31, 2026
						($ in thousands)
Fiscal year 2026						$	95,229
Fiscal year 2027						90,407
Fiscal year 2028						84,373
Fiscal year 2029 and thereafter						276,030
						$	546,039

As of March 31, 2026, we also had $487 million in capital loss carryforwards, $305 million of which will expire by December 31, 2027 and the remainder by December 31, 2028. Due to these amounts and other temporary and permanent differences between GAAP net income and REIT taxable income, coupled with the uncertainty inherent in the forward interest rate curve, we cannot reasonably estimate how much the deferred tax hedge gains to be recognized will impact our dividend declarations during 2026 or in any given period.

We fund dividend distributions through portfolio cash flows, existing cash balances, or through the return of principal from our investments (either through repayment or sale). Please refer to "Operating and Regulatory Structure" within Part I, Item 1, "Business," as well as Part I, Item 1A, “Risk Factors” of our 2025 Form 10-K for additional important information regarding our deferred tax hedge gains and dividends declared on our taxable income.

RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Note 1 of the Notes to the Unaudited Consolidated Financial Statements contained within Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.

CRITICAL ACCOUNTING ESTIMATES

The discussion and analysis of our financial condition and results of operations are based in large part upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities. We base these estimates and judgments on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual results may differ from the estimated amounts we have recorded.

Critical accounting estimates are defined as those that require management's most difficult, subjective, or complex judgments, and which may result in materially different results under different assumptions and conditions.

27

---

Our critical accounting estimates are discussed in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2025 Form 10-K under “Critical Accounting Estimates.” There have been no significant changes in our critical accounting estimates during the three months ended March 31, 2026.

FORWARD-LOOKING STATEMENTS

Certain written statements in this Quarterly Report on Form 10-Q that are not historical facts constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Statements in this report addressing expectations, assumptions, beliefs, projections, future plans and strategies, future events, developments that we expect or anticipate will occur in the future, and future operating results, capital management, and dividend policy are forward-looking statements. Forward-looking statements are based upon management’s beliefs, assumptions, and expectations as of the date of this report regarding future events and operating performance, considering all information currently available to us, and are applicable only as of the date of this report. Forward-looking statements generally can be identified by the use of words such as “believe,” “expect,” “anticipate,” “estimate,” “plan,” “may,” “will,” “intend,” “should,” “could,” or similar expressions. We caution readers not to place undue reliance on our forward-looking statements, which are not historical facts and may be based on projections, assumptions, expectations, and anticipated events that do not materialize. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Forward-looking statements are inherently subject to risks, uncertainties and other factors that could cause our actual results to differ materially from historical results or from any results expressed or implied by such forward-looking statements. Not all these risks and other factors are known to us. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. The projections, assumptions, expectations, or beliefs upon which the forward-looking statements are based can also change as a result of these risks or other factors. If such a risk or other factor materializes in future periods, our business, financial condition, liquidity, and results of operations may vary materially from those expressed or implied in our forward-looking statements.

While it is not possible to identify all factors that may cause actual results to differ from historical results or any results expressed or implied by forward-looking statements or that may cause our projections, assumptions, expectations, or beliefs to change, some of those factors include the following:

•the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, especially those incorporated by reference into Part I, Item 1A, “Risk Factors,”

•our ability to find suitable reinvestment opportunities;

•changes in domestic economic conditions;

•geopolitical events and instability and the related impact on macroeconomic conditions as a result of such related uncertainty;

•tariffs that the U.S. imposes on trading partners or tariffs imposed on the U.S. from trading partners;

•global and domestic government policy changes and the ability or inability to react to rapidly changing economic policies;

•changes in interest rates and credit spreads, including the repricing of interest-earning assets and interest-bearing liabilities;

•our investment portfolio performance, particularly as it relates to cash flow, prepayment rates, and credit performance;

•the impact on markets and asset prices from changes in the Federal Reserve’s policies regarding the purchases of Agency RMBS, Agency CMBS, and U.S. Treasuries;

•actual or anticipated changes in Federal Reserve monetary policy or the monetary policy of other central banks;

•adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies, including in particular China, Japan, the European Union, and the United Kingdom;

28

---

•the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;

•the cost and availability of new equity capital;

•changes in our leverage and use of leverage;

•changes to our investment strategy, operating policies, dividend policy, or asset allocations;

•the quality of performance of third-party service providers, including our sole third-party service provider for our critical operations and trade functions;

•the loss or unavailability of our third-party service provider’s service and technology that supports critical functions of our business related to our trading and borrowing activities due to outages, interruptions, or other failures;

•the level of defaults by borrowers on loans underlying MBS;

•changes in our industry;

•increased competition;

•changes in government policies or regulations affecting our business;

•changes or volatility in the repurchase agreement financing markets and other credit markets;

•changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;

•uncertainty regarding continued government support of the U.S. financial system and U.S. housing and real estate markets, or to reform the U.S. housing finance system, including the resolution of the conservatorship of Fannie Mae and Freddie Mac;

•the composition of the Board of Governors of the Federal Reserve;

•the political environment in the U.S.;

•systems failures or cybersecurity incidents; and

•exposure to current and future claims and litigation.

Regulation FD Disclosures

We routinely announce material information to investors and the marketplace using filings with the SEC, press releases, public conference calls, presentations, webcasts, and the investor relations page of our website at www.dynexcapital.com/investors and our LinkedIn page. We use these channels for purposes of compliance with Regulation FD and as routine channels for distribution of important information. While not all of the information that we post to the investor relations page of our website or to our LinkedIn page is of a material nature, some information could be deemed to be material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. The web addresses are included in this Quarterly Report on Form 10-Q as textual references only and the information posted on these channels are not incorporated by reference in this Quarterly Report on Form 10-Q or in any other report or document we file with the SEC.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the exposure to losses resulting from changes in market factors. Our business strategy exposes us to a variety of market risks, including interest rate, spread, prepayment, credit, liquidity, and reinvestment risks. These risks can and do cause fluctuations in our liquidity, comprehensive income and book value

29

---

as discussed below.

Interest Rate Risk

Investing in interest-rate sensitive investments such as MBS and TBA securities subjects us to interest rate risk. Interest rate risk results from investing in securities with a fixed coupon or a floating coupon that may not immediately adjust for changes in interest rates. Interest rate risk also results from the mismatch between the duration of our assets versus the duration of our liabilities and hedges. The amount of the impact will depend on the composition of our portfolio, our hedging strategy, the effectiveness of our hedging instruments and the magnitude and duration of the change in interest rates.

We manage interest rate risk within tolerances set by our Board of Directors. We use interest rate hedging instruments to mitigate the impact of changing interest rates on the market value of our assets and on our interest expense from repurchase agreements used to finance our investments. Our hedging methods are based on many factors, including, but not limited to, our estimates regarding future interest rates and expected levels of prepayments of our assets. If prepayments are slower or faster than assumed, the maturity of our investments will also differ from our expectations, which could reduce the effectiveness of our hedging strategies and may cause losses that adversely affect our cash flow. Estimates of prepayment speeds can vary significantly by investor for the same security, and therefore, estimates of security and portfolio duration can vary considerably between market participants.

We continuously monitor market conditions, economic conditions, interest rates, and other market activity and adjust the composition of our investments and hedges throughout any given period. As such, the projections for changes in market value provided below are limited in usefulness because the modeling assumes no changes to the composition of our investment portfolio or hedging instruments as of the dates indicated. Changes in the types of our investments, the returns earned on these investments, future interest rates, credit spreads, the shape of the yield curve, the availability of financing, and/or the mix of our investments and financings, including derivative instruments, may cause actual results to differ significantly from the modeled results shown in the tables below.  Therefore, the modeled results shown in the tables below and all related disclosures constitute forward-looking statements.

Management evaluates changes in interest rate curves to manage portfolio interest rate risk and the market value of its investments and common equity. Because interest rates do not typically move in a parallel fashion from period to period (as can be seen by the graph for U.S. Treasury rates in Item 2, “Executive Overview”), the tables below show the projected sensitivity of the market value of our financial instruments and common equity to both parallel and non-parallel shifts in market interest rates.

30

---

						March 31, 2026
						Parallel Decrease in Interest Rates of																								Parallel Increase in Interest Rates of
						100 Basis Points												50 Basis Points												50 Basis Points												100 Basis Points
Type of Instrument (1)						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity
RMBS						3.1		%				29.4		%				1.8		%				17.2		%				(2.2)		%				(20.8)		%				(4.6)		%				(43.7)		%
CMBS						0.2		%				2.2		%				0.1		%				1.1		%				(0.1)		%				(1.0)		%				(0.2)		%				(2.1)		%
CMBS IO						—		%				0.1		%				—		%				—		%				—		%				—		%				—		%				(0.1)		%
TBAs						0.3		%				2.8		%				0.2		%				1.6		%				(0.2)		%				(1.9)		%				(0.4)		%				(4.0)		%
Interest rate hedges						(4.2)		%				(40.2)		%				(2.1)		%				(19.8)		%				2.0		%				19.3		%				4.0		%				38.4		%
Total						(0.6)		%				(5.7)		%				—		%				0.1		%				(0.5)		%				(4.6)		%				(1.2)		%				(11.5)		%
						December 31, 2025
						Parallel Decrease in Interest Rates of																								Parallel Increase in Interest Rates of
						100 Basis Points												50 Basis Points												50 Basis Points												100 Basis Points
Type of Instrument (1)						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity						% of Market Value						% of Common Equity
RMBS						2.3		%				19.1		%				1.4		%				11.6		%				(1.8)		%				(15.1)		%				(3.9)		%				(32.3)		%
CMBS						0.3		%				2.3		%				0.1		%				1.2		%				(0.1)		%				(1.1)		%				(0.3)		%				(2.2)		%
CMBS IO						—		%				0.1		%				—		%				—		%				—		%				—		%				—		%				(0.1)		%
TBAs						0.7		%				5.6		%				0.4		%				3.2		%				(0.4)		%				(3.7)		%				(0.9)		%				(7.6)		%
Interest rate hedges						(4.4)		%				(36.7)		%				(2.2)		%				(18.2)		%				2.2		%				17.8		%				4.3		%				35.7		%
Total						(1.1)		%				(9.6)		%				(0.3)		%				(2.2)		%				(0.1)		%				(2.1)		%				(0.8)		%				(6.5)		%

																		March 31, 2026												December 31, 2025
Non-Parallel Shifts						Basis Point Change in 2-year UST						Basis Point Change in 10-year UST						% of Market Value (1)						% of Common Equity						% of Market Value (1)						% of Common Equity
Bearish			Steepening			+25						+50						(0.4)		%				(3.7)		%				(0.2)		%				(1.4)		%
						+50						+100						(1.1)		%				(10.1)		%				(0.6)		%				(5.3)		%
			Flattening			+50						+25						(0.3)		%				(2.8)		%				(0.2)		%				(1.4)		%
						+100						+50						(0.7)		%				(6.4)		%				(0.4)		%				(3.4)		%
Bullish			Steepening			-50						-25						0.2		%				1.4		%				—		%				—		%
						-100						-50						0.1		%				1.2		%				(0.2)		%				(1.7)		%
			Flattening			-25						-50						(0.1)		%				(0.7)		%				(0.3)		%				(2.8)		%
						-50						-100						(0.8)		%				(7.1)		%				(1.3)		%				(10.6)		%

(1)Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings which are not carried at fair value on our balance sheet due to their short-term maturities. The projections for market value do not assume any change in credit spreads.

31

---

Spread Risk

Spread risk is the risk of loss from an increase in the market spread between the yield on an investment versus its benchmark index. Changes in market spreads represent the market's valuation of the perceived riskiness of an asset relative to risk-free rates. Widening spreads reduce the market value of our investments as market participants require additional yield to hold riskier assets. Market spreads could change based on macroeconomic or systemic factors as well as the factors specific to a particular security, such as prepayment performance or credit performance. Other factors that could impact credit spreads include technical issues, such as supply and demand for a particular type of security, Federal Reserve monetary policy, or other governmental policy change. We do not hedge spread risk given the cost and complexity of hedging credit spreads and, in our opinion, the lack of liquid instruments available to use as hedges.

Fluctuations in spreads typically vary based on the type of investment. Sensitivity to changes in market spreads is derived from models that are dependent on various assumptions, and actual changes in market value in response to changes in market spreads could differ materially from the projected sensitivity if actual conditions differ from these assumptions.

The table below shows the projected sensitivity of the market value of our investments given the indicated change in market spreads as of the dates indicated:

						March 31, 2026												December 31, 2025
						Percentage Change in												Percentage Change in
Basis Point Change in Market Spreads						Market Value of Investments (1)						% of Common Equity						Market Value of Investments (1)						% of Common Equity
+20/+50 (2)						(1.1)		%				(10.1)		%				(1.0)		%				(8.4)		%
+10						(0.5)		%				(5.0)		%				(0.5)		%				(4.2)		%
-10						0.5		%				5.0		%				0.5		%				4.2		%
-20/-50 (2)						1.1		%				10.1		%				1.0		%				8.4		%

(1) Includes changes in market value of our MBS investments, including TBA securities.

(2) Assumes a 20-basis point shift in Agency and non-Agency RMBS and CMBS and a 50-basis point shift in Agency

and non-Agency CMBS IO.

Other Market Risks

In addition to the risks discussed above, we are also subject to prepayment risk, credit risk, liquidity risk, and reinvestment risk. We have not experienced any material changes in these risks during the three months ended March 31, 2026. Please refer to Part I, Item 1A, “Risk Factors,” and Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risks,” in our 2025 Form 10-K for further discussion.

ITEM 4.    CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management evaluated, with the participation of our co-principal executive officers and principal financial officer, the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, our co-principal executive officers and principal financial officer concluded that, as of March 31, 2026, our disclosure controls and procedures were effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our co-principal executive officers and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

32

---

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended March 31, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.    OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

To the Company’s knowledge, there are no pending or threatened legal proceedings, which, in management’s opinion, individually or in total, could have a material adverse effect on the Company’s results of operations or financial condition.

ITEM 1A.    RISK FACTORS

There have been no material changes from the risk factors discussed in Part I, Item 1A, “Risk Factors” of our 2025 Form 10-K. Risks and uncertainties identified in our forward-looking statements contained in this Quarterly Report on Form 10-Q together with those previously disclosed in the 2025 Form 10-K or those that are presently unforeseen could result in significant adverse effects on our financial condition, results of operations and cash flows. See “Forward-Looking Statements” contained in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q as well as Part I, Item 1A, “Risk Factors” in our 2025 Form 10-K.

ITEM 2.    UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The Company’s Board of Directors approved a new share repurchase program (the “Program”) authorizing the repurchase of up to $300 million of its common stock and up to $50 million of its preferred stock, including any series thereof currently or hereafter authorized. Under the Program, repurchases may be made from time to time through open market transactions, privately negotiated transactions, or other means, including, without limitation, trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act. The actual means and timing of any repurchases under the Program will depend on a variety of factors, including, without limitation, the market prices of its common Stock and preferred stock, as applicable, general market and economic conditions, and applicable legal and regulatory requirements. The Program is authorized through April 30, 2028, and replaces the Company’s prior repurchase program, which was set to expire on April 30, 2026. The Program does not require the Company to purchase any shares and may be modified, suspended, or terminated by the Board at any time.

The Company did not repurchase any shares of its common stock or Series C Preferred Stock during the three months ended March 31, 2026. Employees forfeited 168,758 common shares to cover payroll tax withholding on share-based compensation that vested during the three months ended March 31, 2026.

33

---

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

        

        None.

ITEM 5.    OTHER INFORMATION

Rule 10b5-1 Trading Plan

During the three months ended March 31, 2026, none of the Company’s directors or Section 16 officers adopted or terminated any “Rule 10b5-1 trading arrangements” or any “non-Rule 10b5-1 trading arrangements” (in each case, as defined in Item 408 of Regulation S-K).

ITEM 6.    EXHIBITS

Exhibit No.			Description
3.1			Restated Articles of Incorporation, effective May 14, 2021 (incorporated herein by reference to Exhibit 3.1 to Dynex's Current Report on Form 8-K filed May 18, 2021).
3.1.1			Second Articles of Amendment to the Restated Articles of Incorporation, effective as of May 21, 2025 (incorporated herein by reference to Exhibit 3.1.1 to Dynex’s Current Report on Form 8-K filed May 21, 2025).
3.2			Amended and Restated Bylaws, effective as of May 11, 2021 (incorporated herein by reference to Exhibit 3.2 to Dynex’s Current Report on Form 8-K filed May 12, 2021).
4.1			Specimen of Common Stock Certificate (incorporated herein by reference to Exhibit 4.1 to Dynex's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019).
4.2			Specimen of 6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock Certificate (incorporated herein by reference to Exhibit 4.4 to Dynex's Registration Statement on Form 8-A12B filed February 18, 2020).
4.3			Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (incorporated herein by reference to Exhibit 4.3 to Dynex’s Annual Report on Form 10-K for the year ended December 31, 2024).
10.1			Separation Agreement and General Release between Dynex Capital, Inc. and Robert S. Colligan, executed as of March 22, 2026 (filed herewith).
10.2			Performance Unit Award Agreement for award granted March 4, 2026 under the Company’s 2025 Stock and Incentive Plan between Dynex Capital, Inc. and Robert S. Colligan (filed herewith).
10.3			Restricted Stock Unit Award Agreement for award granted March 4, 2026 under the Company’s 2025 Stock and Incentive Plan between Dynex Capital, Inc. and Michael A. Sartori (filed herewith).
31.1			Certification of co-principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2			Certification of co-principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.3			Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1			Certification of co-principal executive officers and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101			The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to the Unaudited Consolidated Financial Statements.
104			The cover page from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language) (included with Exhibit 101).

* Denotes a management contract or compensatory plan or arrangement.

34

---

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

									DYNEX CAPITAL, INC.
Date:			April 27, 2026						/s/ Michael A. Sartori
									Michael A. Sartori
									Chief Financial Officer
									(Principal Financial Officer)

35